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In 2018, Medicare spending in the United States accounted for 15% of the comprehensive 
federal budget forecasted to exceed $1.5 trillion by the year 2028. To help manage the 
spending in this sector, the Centers for Medicare and Medicaid Services implemented 
Medicare Shared Savings Program (MSSP) Accountable Care Organizations (ACOs). 
There is a need to understand current data as it relates to the correlation between MSSP 
ACO participants’ costs, quality, and assigned beneficiaries. The purpose of this 
quantitative study was to examine the relationship between Quality Score, Generated 
Total Savings/Losses and Total Assigned Beneficiaries for 2018 MSSP ACO 
participants. General systems theory was the theoretical base that grounded and 
conceptualized this study. The key research questions examined the relationship between 
the Quality Score and Generated Total Savings/Losses for 2018 MSSP ACO participants 
and the relationship between the Quality Score and Total Assigned Beneficiaries for 2018 
MSSP ACO participants. The research design was that of secondary data quantitative 
analysis. The analytics stem from public CMS data. Even though the data analysis results 
showed no statistically significant relationship between Quality Score and Generated 
Total Savings/Losses nor between Quality Score and Total Assigned Beneficiaries for 
2018 MSSP ACO provider participants, this study contributed to positive social change 
by creating a new vantage point for review of their quality, costs, and assigned 
beneficiaries. The development and understanding of ACO initiatives are essential pieces 
required for meeting federal value-based care and alternative payment model U.S. health 
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Section 1: Foundation of the Study and Literature Review 
Fragmentation and misalignment in the U.S. health care system created an 
opportunity for reforms of its payment and delivery methods. Traditionally, U.S. health 
care has reimbursed providers via fee-for-service (FFS) payment structures. FFS has had 
an unintended consequence of incentivizing volume (or increasing number) of services 
over quality, outcomes-based, or higher value services. There have been various 
historical attempts to rein in health care costs while concurrently increasing quality; with 
a goal of improving overall delivery. As an example, the overarching Accountable Care 
Organization (ACO) model has a modern goal of improving population health and 
reducing per capita costs (Tu et al., 2015). The Centers for Medicare and Medicaid 
Services (CMS) created ACOs in Section 3022 of the Patient Protection and Affordable 
Care Act (ACA) of 2010 as an Alternative Payment Model (APM) to begin the shift of 
the U.S. health care environment from volume to value. Title 42 CFR Part 425 (2018) 
outlined the requirements for participation in the Medicare Shared Savings Program 
(MSSP).  
As detailed in the literature review, Medicare ACOs have various strategies in 
terms of the different offerings and participation numbers in each performance year. The 
MSSP is the largest ACO developed to date. No termination currently exists for MSSPs. 
On the contrary, MSSPs have been further recognized and empowered via the passing of 
the Medicare Access and Children’s Health Insurance Program (CHIP) Reauthorization 
Act (MACRA) of 2015. The MACRA’s Quality Payment Program (QPP) includes a 
component of achievement that relies on MSSPs being successful (TXCIN, 2018).  
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In 2013, the CMS implemented the MSSP, a years-long strategy and 
multipronged approach to help reform Medicare and ensure the sustainability of the 
sector. In essence, MSSP ACOs agree to be accountable for the patient experience, cost, 
and quality of their assigned Medicare FFS beneficiary population. (TXCIN, 2018). 
Spending on Medicare is nearly one fifth of total U.S. health care costs (Cubanski 
et al., 2019). To help better manage the spending of the Medicare sector of the U.S. 
health care industry for taxpayers and concurrently promote high-quality care for 
beneficiaries, the CMS has implemented MSSP ACOs (CMS, 2019). This study reviewed 
the Total Assigned Beneficiaries, Generated Total Savings/Losses and Quality Score of 
2018 MSSP ACOs. This study needed to be conducted on a micro level to note the 2018 
performance year relationship of quality and cost indicators for the managed population 
of the MSSP. On a macro level, this study needed to be conducted to understand the 
impact MSSPs are having on the overarching U.S. health care goals to increase quality 
and decrease costs for managed populations in the Medicare space, moving more towards 
value-based care. The positive social changes of this study include understanding the 
relationship between quality, cost, and total assigned beneficiaries and related movement 
toward value-based care in terms of lowered costs and increased quality for the U.S. 
health care system, specifically stemming from 2018 MSSP ACOs. From a quality 
perspective, this is critical for Medicare beneficiaries, and from a cost perspective, this is 
important for U.S. taxpayers.  
The major sections of this chapter include (a) Problem Statement; (b) Purpose of 
the Study; (c) Research Questions and Hypotheses; (d) Theoretical Foundation of the 
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Study; (e) Nature of the Study; (f) Literature Search Strategy; (g) Literature Review 
Related to Key Variables and Concepts; (h) Definitions; (i) Assumptions; (j) Scope and 
Delimitations; and (k) Significance, Summary, and Conclusions.  
Problem Statement 
Per the U.S. Department of Health and Human Services (DHHS, 2019), Medicare 
spending is forecasted to exceed $1.5 trillion by 2028. Medicare-specific costs account 
for about 20% of the total health spending nationwide. In 2018, Medicare took up an 
estimated 15% of the comprehensive federal budget (Cubanski et al., 2019). To manage 
the spending of this sector of the U.S. health care industry for taxpayers and concurrently 
promote high-quality care for Medicare beneficiaries, the CMS has reviewed new and 
innovative ways to move away from FFS with a focus toward value-based care payment 
models. The payment models seek to reward providers for the overall value (measured by 
decreased cost and improved quality) of health care services. To date, although the CMS 
has implemented an array of APMs to achieve its goals, the MSSP, founded in 2010, is 
one of the center’s largest APMs to encourage cost efficient and quality care services 
(CMS, 2019). Mostashari and Broome (2016) reported that there is still much debate over 
whether ACOs have been successful in delivering value. Wegner (2016) defined health 
care value as a measurement of the quality of care and cost of care. Falk (2016) noted that 
if the CMS is sincerely interested in seeing Medicare reimbursements tied to value, 
confidence in the future of MSSPs must be instilled; additional research can work to 
reveal whether it takes further participation in accountable care to realize the full effects 
that coordination efforts can have on the cost and quality of U.S. health care.  
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Previous research has shown that there is a need to understand future years’ data 
(Falk, 2016) as it relates to whether MSSP ACO participants render health care services 
to their total assigned beneficiaries that are of lower cost (i.e., by means of generated 
CMS cost savings) and higher quality (i.e., determined via established benchmarks and 
quality improvement efforts), thereby demonstrating a gap in research. Falvey (2017) 
mentioned that health care leaders who have launched ACOs, or debate the future of 
population health, need results generated from studies such as this to maintain current 
ACOs and their strategic approach while also potentially demonstrating the need to 
establish additional ACO-like initiatives. The development of ACOs is the essential piece 
required for managing an assigned beneficiary pool via population health management. 
MSSP ACOs were established by the ACA to implement initiatives aimed at reducing 
costs and improving care for an assigned beneficiary pool (Corder, 2018). Perez (2015) 
posited that ACOs have the most significant potential to concurrently lower costs and 
improve quality. This research is important to the health care administration discipline for 
many reasons, but most importantly, to understand the relationship between costs, 
quality, and assigned beneficiaries within MSSP ACOs, specifically in the 2018 
performance year. 
Purpose of the Study 
This study utilized a secondary data quantitative approach to address the research 
questions. The statistics consisted of public data from CMS, a federal resource, for the 
MSSP ACO 2018 performance year. This allowed me, as the scholar-practitioner, to 
employ recent data via a standard analytical file that was used to efficiently summarize 
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information for beneficiaries and providers for the specific ACO 2018 performance year 
of the MSSP. The research demonstrated that MSSP ACOs are an avenue that can be 
utilized to ensure lower costs and increased quality as it relates to serving the Medicare 
FFS population. With a national gross domestic product (GDP) of nearly 20% (Cubanski 
et al., 2019), the United States must roll back the unconscionable costs and crouched 
quality that resides in its health care renderings to ensure sustainability and affordability 
for the entire system; innovation in the Medicare space is critical to the larger goal. 
The purpose of this quantitative study, which differentiates it from others 
published, was to understand the relationship between Quality Score and Generated Total 
Savings/Losses within MSSP ACO participants in the 2018 performance year and to 
understand the relationship between Quality Score and total assigned beneficiaries within 
MSSP ACO participants in the 2018 performance year. The literature notes that MSSP 
ACOs are a viable option for U.S. health administrators to reach systemic goals due to 
their effect on cost and quality; they can not only save the federal government, revenue 
via taxpayers, billions of dollars as years progress and initiatives become more innovative 
and collaborative, but also ensure care quality is enhanced (National Association of 
ACOs, 2018). The need for this study lay in noting the relationship between certain 
variables to review and understand how MSSP ACOs can improve quality and costs 
savings, allowing for further expansion of accountable, value-based care.  
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Table 1  





CMS long description 
N_AB Total assigned 
beneficiaries 
Number of assigned beneficiaries, performance year 
GenSaveLoss Generated total 
savings/losses 
(Gross) Generated savings: Total savings (measured 
as Benchmark Minus Expenditures, from first to last 
dollar) for ACOs whose savings rate equaled or 
exceeded their Minimum Savings Rate (MSR). This 
amount does not account for the application of the 
ACO’s final sharing rate based on quality 
performance, reduction due to sequestration, 
application of performance payment limit or 
repayment of advance payments. (Gross) Generated 
losses: Total losses (measured as Benchmark Minus 
Assigned Expenditures, from first to last dollar) 
ACOs in Track 2, Track 3, or the Track 1+ Model 
whose losses rate equaled or exceeded their Medical 
Loss Ratio (MLR). This amount does not account for 
the application of the ACO’s final sharing rate based 
on quality performance (for Track 2 or 3 ACOs) or 
the loss sharing limit. 
QualScore Quality score Quality score: In Performance Year 1 of an ACO’s 
first agreement period, the quality score is 100% if all 
measures were completely reported and less than 
100% if one or more measures were not completely 
reported. Beyond Performance Year 1 of an ACO’s 
first agreement period, the quality score will be 
determined not only by whether all measures were 
completely reported but also on their performance 
against established benchmarks and on quality 
improvement. For ACOs determined to have been 
affected by a natural disaster, the quality score is the 
higher of the ACO's calculated initial quality score or 
the national mean quality score across all Shared 
Savings Program ACOs who met the quality 
performance standard. 
Note. (Centers for Medicare & Medicare Services, 2020) 
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The study’s variables were Generated Total Savings/Losses, Quality Score, and 
Total Assigned Beneficiaries. For Research Question 1 (RQ1), the study’s independent 
variable (IV) was Quality Score and the dependent variable (DV) was Generated Total 
Savings/Losses in the 2018 MSSP ACO performance year. For Research Question 2 
(RQ2), the study’s independent variable was Total Assigned Beneficiaries and the 
dependent variable was Quality Score in the 2018 MSSP ACO performance year. The 
definitions of variables are presented in Table 1 and in the Definitions section of this 
study. 
ACO Tracks (inclusive of Track 2, starting in 2012, and Track 3, starting in 2016) 
vary in terms of their financial structures, beneficiaries, data and quality reporting 
requirements, compliance, and waivers. Medicare requires ACOs to report the quality 
measures which are composed of 33 nationally recognized measurements in four 
categories: patient experience, care coordination/patient safety, preventative health, and 
five different at-risk populations. Afterward, the Quality Score is determined not only by 
whether measures were completed reported or not, but also on the ACO’s performance 
against certain quality improvement initiatives and established benchmarks (CMS, 2020).  
Research Questions and Hypotheses 
RQ1: Is there a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants?  
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H01: There is no statistically significant relationship between the Quality Score 
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
H11: There is a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
RQ2: Is there a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants? 
H02: There is no statistically significant relationship between the Quality Score 
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
H12: There is a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants. 
Theoretical Foundation for the Study 
General systems theory (GST) is the theoretical base that grounded and 
conceptualized this study. Von Bertalanffy (1968) wrote that a system is complex with 
interacting elements, continually evolving parts, and emerging properties. GST covers 
broadly applicable concepts and principles in dynamic and active systems with 
behavioral and process-based interactions. The theory allows the researcher to review the 
various layers that exist in the system to relate them and study their intersecting trends 
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and patterns. GST is a framework that can be used to help understand, design, and 
analyze ways to investigate how value-based care may help improve the U.S. health care 
system and understand the relationship among the related variables such as quality, cost, 
and beneficiaries. The theory can help examine specific MSSP ACO performance years 
and note how those ACOs behave in the ever-changing health care environment, specific 
to quality, costs, and beneficiaries.  
In this particular study, the way quality, cost of care and assigned population push 
and pull on each other in the overall system were studied in terms of their interrelatedness 
and their interdependence in health care to better understand effects on affordability and 
sustainability. The advent of MSSP ACOs has created an avenue of accountability 
whereby Medicare costs can arguably be contained and measured, and actionable insight 
can be offered via coordination and the encouragement of investing in efficient services 
(CMS, 2019). This layer of an already complex overarching system will give rise to 
picking apart specific quality, cost and beneficiary data that can be extracted to 
understand the relationship and positively impact the whole. The variables of this study 
were related to GST in part because although there are multiple outcomes that MSSP 
ACOs measure to ensure efficient, coordinated care, quality scores are key clinical 
metrics with various elements that have a relationship with costs and assigned 
beneficiaries and an effect on the overall system. A competitive strategic approach for 
health care administrators leading various health care organizations is in many ways 
dependent on properly understanding the relationship of quality and cost measures to the 
population under organizational management (Arsita & Idris, 2019).  
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Nature of the Study 
For this study, I used a secondary data quantitative approach to address the two 
research questions. The data statistics consisted of public data from CMS, a federal 
resource, for the MSSP ACO 2018 performance year. This allowed me to employ recent 
data via a standard analytical file that I used to efficiently summarize information for 
beneficiaries and providers for the specific performance year of the MSSP. This research 
study noted the relationship amongst cost, quality and beneficiaries and yielded thoughts 
and potential further research on the notion that MSSP ACOs can help lower costs and 
increase quality as it relates to serving the U.S. Medicare population. Since nearly one 
fifth of the U.S. GDP is spent on healthcare (Cubanski et al., 2019), the nation must find 
more innovative, sustainable, and affordable ways to render health care services. 
Understanding the relationship between Quality Score, Generated Total Savings/Losses 
and Total Assigned Beneficiaries can serve as a tool in the overarching review of MSSP 
ACOs as an innovative opportunity to ensure sustainability and affordability of the U.S. 
health care system.  
Literature Search Strategy 
Selected articles related to the study were found by searching keywords and/or 
phrases such as CMS MSSP ACOs, Medicare Shared Savings Program, accountable 
care, Accountable Care Organizations, value-based care in U.S., Medicare payment 
innovation, alternative payment models, quality, cost, attributed beneficiaries, Total 
Assigned Beneficiaries, Generated Total Savings/Losses, and Quality Score. Databases 
used included, but were not limited to, EBSCOhost, CINAHL Plus with Full Text, 
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MEDLINE with Full Text, ProQuest, and Science Direct. The scope of the literature 
review spanned the years from 2015 to 2020. The types of literature used for this study 
were peer-reviewed journal articles, reputable online and textbook works, as well as 
esteemed commissions by distinguished, prominent, and renowned authors. 
Literature Review Related to Key Variables and Concepts 
In reviewing the literature as it relates to accountable health care in the U.S., I 
analyzed peer-reviewed journal articles, dissertations, doctoral and master-level studies, 
and other scholarly resources on the topic of accountable and value-based care; 
specifically, transformation, initiatives, realizations, evolution and MSSP ACO 
relationships.  
Accountable Care Transformation 
Fundamentally, the U.S. health care system has, for years, had perverse 
incentives. Providers have been paid based mostly on the volume of services rendered 
and when patients become/are sick. As a result of this historical volume-driven utilization 
model, a new wave of outcome (or value)-based agreements is emerging from not only 
Medicare payment methods, but also various commercial, Medicaid, as well as other 
health plans and managed care organizations. These advents include quality measurement 
and shared financial savings/losses with providers. When providers participate in value-
based health care models, there is an innate risk, sometimes inclusive of upside and/or 
downside financial agreements. However, if and/or when providers accept the risk, they 




Secretary of DHHS, Alex Azar, has declared that rendering value-based health 
care in the United States must dramatically accelerate to deliver health care outcomes 
commensurate with current and future health care costs (Leonard, 2018). Azar has made 
it clear that the current, aforementioned volume-based, system is not working well 
enough for Medicare beneficiaries nor taxpayers, and the U.S. health care system must 
make more than just incremental steps in disrupting arrangements that currently exist 
(Leonard, 2018). Failure to successfully incorporate accountable care into the 
overarching system will likely result in monetary losses, less access to care for patients as 
well as reduced quality of care (Pierce, 2018).  
Historically, there have been mixed results in the research regarding population 
health and its related impact and sustainability in terms of meeting cost and quality goals, 
as noted in Leighton’s (2019) research on the provider and organizational response to 
population health management initiatives. In the qualitative study, Leighton used 
Medicare administrative claims data, observations, interviews, and document reviews to 
understand better processes, structures, and performance between MSSP ACO provider 
networks and maintenance of attributed beneficiaries. There have been organizations that 
improved care processes and positively modified health care provider behavior, but 
context matters when noting driving change factors and overall performance. The 
adjusted logistic regression results indicated highly comprehensive ACO provider 
networks having a positive impact on the retention of attributed beneficiaries. 
Generalized linear models were used to test the hypotheses related to changes in provider 
operations (Leighton, 2019).  
13 
 
Transformation achievement in the U.S. health care system is extensive, time-
consuming, daunting, and undoubtedly feels foreign to some stakeholders. However, as 
Medicare is currently the nation’s largest purchaser of health care in the United States, 
and the MSSP is one of the broadest APMs, the federal payer, CMS, and related Center 
for Medicare and Medicaid Innovation, has been the impetus for driving change. 
Systemic, yet flexible; complex, yet straightforward – CMS has continued to forge ahead 
with implementing various types of MSSP ACOs to ensure effective, coordinated, 
fiscally responsible health care of sound quality for beneficiaries. ACOs are a vital 
component of the overall U.S. health care long-term strategy in moving toward value-
based care. Medicare ACO design includes the provision of financial incentives to reduce 
health care delivery inefficiencies for a specific population (TXCIN, 2018). Success of 
value-based care and its ability to move the U.S. health care system toward higher quality 
and lower costs will depend on understanding the markers of ACO success thus far, a 
continuation of initiatives that have worked well, and a development of increased 
innovation geared towards improved quality and reduced costs (Moloney, 2015).  
In ACOs, alignment between hospitals and physicians on patient care is driven by 
cost control and quality improvement endeavors. Clinical integration and 
interorganizational relationships are aimed at minimizing constraints, improving 
efficiencies, implementing strategies to address challenges related to limited resources, 
and coordinating patient care between inpatient, outpatient, and physician office services 
for appropriate care management as well as share centralized administrative services. 
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ACOs require meaningful collaboration as well as data sharing and integration (Harrison 
et al., 2018). 
Under FFS models, providers can receive reimbursement for tests and procedures 
rendered with no reward nor penalty related to whether those services impacted patient 
quality of care outcomes or costs (LaPointe, 2017). Accountable, value-based care via 
APMs, however, creates a financial responsibility, or risk-based approach, for providers 
as it pertains to the health care services provided. Upside risk, or one-sided financial risk, 
allows provider participants to share in specific cost savings initiatives alongside the 
payer if the providers’ rendered services make care delivery more efficient in higher 
quality and lowered costs (LaPointe, 2017). If costs exceed the agreed-upon benchmark, 
upside-only, or one-sided risk, provider participants do not qualify for any shared savings 
payments or financial incentives, but those providers are not penalized; they are held 
harmless from a cost perspective. Meaning, the upside-only, or one-sided risk provider 
can earn a financial reward if they meet the benchmark, but, good for the provider, have 
no chance of penalty if they do not meet the criterion. Upside-only, one-sided (payer) risk 
arrangements are typically preferred by providers as the providers have no risk of losing 
or paying back money to the payer; only an opportunity to be rewarded financially 
(LaPointe, 2017). Downside risk, or two-sided risk, promotes accountability on behalf of 
the provider in partnership with the payer. In this model, provider participants share in 
financial savings and losses. The provider is at shared, two-sided, inclusive of downside, 
the risk for saving and losing money in the shared-risk arrangement with the payer. 
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Shared risk models do not always equate to fifty percent division; sometimes payers take 
on more of the risk than the providers, for example. (LaPointe, 2017). 
Kruthoff (2017) noted that the existence of downside risk, while currently still 
voluntary, is an indication that the U.S. federal government looks to shift further and 
scale more broadly to this kind of arrangement to transform the health care delivery 
system to become more aligned with health and wellbeing goals. Advocates of population 
health management may consider demonstrating the positive impact these changes can 
have on more robust and greater structures.  
Integrated health care delivery networks have an opportunity under ACO program 
rules to function as population health networks (Falvey, 2017). These networks integrate 
clinical processes to improve outcomes for certain populations while reducing the related 
costs and enhancing the patient experience (Falvey, 2017). These assumptions are 
beneficial for launching ACOs, but future research may want to better understand panel 
size, patient demographics, and other influential outcome variables (Falvey, 2017).  
Risk mitigation treatment (RMT) is a health care providers' ability to render 
additional activities to reduce morbidity (Franklin, 2017). These clinical interventions 
reducing specific patient risks can make incremental differences but may be subject to 
diminishing returns. An example of RMT is care coordination/management for high-risk 
demographic groups such as the chronically ill. Franklin used a simulation model design 
to test theoretical perspectives on prevention-oriented clinical services. The resulting 
finding was analyzed to show a positive correlation between changing payment systems 
and significant provider-induced demand changes (Franklin, 2017).  
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The declining functional ability of senior patients and the impact on accountable 
care costs and quality (Kornuszko-Story, 2018). Conducted via a budget impact analysis 
and interviews, potential cost savings and patient function were analyzed. The resulting 
indications were that specific facilities could save millions of dollars while the ACO 
could reduce discharges and readmissions for further cost savings all while creating a 
culture of mobility that would have a positive impact on quality (Kornuszko-Story, 
2018).  
ACOs and the MSSP 
Of all health care payment and delivery systems reforms included in the ACA, 
ACOs may have the most significant potential to improve quality and reduce cost 
simultaneously. At their core, ACOs embody the pillars of value-based health care 
(Perez, 2015). The ACA created a health care industry catalyst with the idea of value 
over volume, with providers sharing in Medicare cost savings and focusing on population 
health. APMs and care delivery reforms in the United States have increased in popularity 
as it relates to their ability to lower health care costs. One of the key components of 
success in the program can be attributed to leveraging data for patient care tracking and 
service renderings outside of the typical settings. Understanding patient care patterns both 
in and out of the ACO network is essential to organizations reducing waste and limiting 
unnecessary services. Forward-thinking strategic relationships and innovative 
partnerships outside of the ACO, such as those with high-value post-acute facilities, 




Table 2  
Medicare ACO Strategy 








Higher levels and 
multiple options of 
savings and risk 
than the MSSP. 
Possible transition 
to population-based 
payment in year 3. 












payments for certain 
eligible physician-
based and rural 
providers already in 
or interested in the 
MSSP 


















payments given on 
expected shared 
savings for MSSP 
ACOs to test pre-
paid savings in rural 
and underserved 
areas. 







Earn up to 50% of 
shared savings. No 
risk of loss. 
Payment capped at 
10% of benchmark 
 *217 399 340 412 438 460 
 Track 1+ 
Earn up to 50% of 
shared savings. Risk 
      *55 
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loss is 30% fixed. 
Payment capped at 
10% of benchmark 
 Track 2 
Earn up to 60% of 
shared savings. Risk 
loss is 40%-60%. 
Payment capped at 
20% of benchmark 
 #3 3 5 6 6 8 
 Track 3 
Earn up to 75% of 
shared savings. Risk 
loss is 40%-75%. 
Payment capped at 
20% of benchmark 









Earn 80%-100% of 
shard savings. 
Minimum Savings 








discharge home visit 
waivers. 









Multiple options of 
savings and risk. 
Designed for End-
Stage Renal Disease 
beneficiaries 
receiving dialysis 
services. First ACO 
with disease specific 
focus. 
    *13 37 37 





Table 3  
ACO Types and Descriptions 
ACO Type Description 
Independent Physician Group A single organization that directly 
provides outpatient care. 
Physician Group Alliance Multiple organizations that directly 
provide outpatient care. 
Expanded Physician Group Directly provides outpatient care and 
contracts for patient care. 
Independent Hospital A single organization that directly 
provides inpatient care. 
Hospital Alliance Multiple organizations with at least one 
that directly provides inpatient care. 
Full-Spectrum Integrated All services provided directly by the 
ACO. May include one or multiple 
organizations. 
 
The CMS intentionally did not provide specific organizational requirements for 
MSSP ACOs. As such, current MSSP ACOs consist of academic medical centers, 
physicians, hospitals, independent practitioners, multi-specialty groups, Clinically 
Integrated provider Networks (CINs), Federally Qualified Health Centers (FQHCs), or a 
combination of the aforementioned. As such, the Medicare beneficiary population within 
the organizations have diverse demographic and health status patterns. It is not clear 
whether the success of MSSP ACOs is due to beneficiary characteristics or that of market 
or organizational distinctions. Ouayogode et al. (2017) posited that probable factors for a 
MSSP ACO's success include several elements such as beneficiary turnover and 
engagement, patient targeting, individual care management plans, evidence-based 
medicine, electronic health records, historical spending analysis, and geographic 
allocation. To that end, organizational and administrative infrastructure, care 
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management proficiencies, and clinical integration are arguably the most important ACO 
performance factors.  
Accountable Care Initiatives 
Powers et al. (2018) noted that ACOs work to control health care spending 
effectively; they are a leading player in delivery system reform and value-based payment 
models. As their growth will continue regardless of the political party in charge, there is 
reason to remain optimistic about the staying power of ACOs. With that, there are some 
important implementation lessons to recall when engaging practices in building 
Medicare-specific ACOs. Whether smaller in size or independent from hospital 
ownership, key factors of practice engagement in value-based care include a dedicated 
staff geared toward population health management expertise, practice transformation 
strategies, clinical productivity as well as actionable, insightful data sharing, analytics, 
and user experience.  
The goal of ACOs is to improve the value of health care as soon as possible. 
However, it takes time to develop and maintain an infrastructure that is organized enough 
to plan, implement, and deploy; strong enough to maintain; and robust enough to scale 
outcomes-based care that will overhaul current care processes (Bleser et al., 2019).  
Payers that take the proper time, resources, and thoughtful planning to launch 
effective value-based care programs can experience overall health care service 
improvements over FFS reimbursement. Strong partnerships, provider engagement and 
outreach, data sharing, cost management and quality measurement are all critical 
components of success in an APM. Properly implemented population health management 
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efforts, such as preventive care service offerings as well as quality and utilization 
management and review can yield better beneficiary healthcare patterns (Beaton, 2018).  
Implementing appropriate strategic health care coordination efforts can improve 
transitions of care and allow for reductions in waste, curtail duplication of services, and 
galvanize interoperability efforts. Some examples of possible interventions across the 
health care continuum include appropriately shifting care from inpatient to lower-cost 
outpatient settings, proactive planning for hospital discharges, medication reconciliation, 
advancements in health information technology, managing integrated complex care teams 
and increasing engagement of beneficiaries and providers (Kaufman et al., 2017). 
However, conceptualization, development, implementation, integration, management, 
optimization, and transformation look different among various ACO types; stakeholders 
undertake performance enhancements differently. Clarification of universally accepted 
design and execution strategies could provide important insight into structural successes 
(Comfort, 2019).  
Data analytics serve an important role in allowing for visualization and actionable 
insights of ACO initiatives, results, and potential next steps. Alsleben (2016) posited that 
efficiently using healthcare data can increase positive patient outcomes. Proper use of 
data analytics allows for more proactive population health management and related 
strategy implementation. The technology can engage the care team and provide real-time 
suggestions that could positively impact patients at the point of care. Additionally, data 
exchange standards and interoperability can be incorporated to further mature the 
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collaborative care in sharing and gaining access to information more efficiently and 
effectively and in real-time. 
Current research notes that integrated networks (such as ACOs) have an 
assumptive positive relation on clinical outcomes. Falvey (2017) examined primary care 
providers in one integrated health care delivery network (IDN). Linear regression 
analyses were performed to analyze a specific subset of disease states; processes, and 
IDN outcomes. The study results concluded that proper use of evidence-based clinical 
guidelines, as often followed in IDNs, had a positive association with better clinical 
quality outcomes, noting the effectiveness of integration. 
Integration with other provider types is an important component of ACO success. 
Social Determinants of Health (SDOH), Behavioral Health (BH), environmental sciences, 
cultural needs, long-term care, and other ancillary service offerings (such as access to 
dental, vision, hearing, and transportation needs) impact the managed population’s 
overall health (McDonough, 2016). Collaborating with and incorporating the needs of 
other health care service offerings assists in addressing a deeper, broader range of patient 
care needs and better achieving health outcomes. A focus on the overall quality of care 
rendered versus the quantity of services provided is the basis of value-based care 
(McDonough, 2016).  
Accountable care policies and procedures have administrative, programmatic, and 
practical implications. For example, initiatives such as End of Life (EoL) care are 
important to the overall success of ACOs. The level of aggressiveness of EoL care as 
well as hospice utilization patterns and levels impact an ACO’s outcome measures (Kim, 
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2018). Similarly, Skilled Nursing Facility (SNF) use and related coordination is also an 
initiative that could increase overall quality outcomes and financial performance of the 
organization (Shipp, 2019). The development of preventive care models for the aging and 
chronically ill subpopulations are community and public health imperatives. Advanced 
and more mature preventive care models geared toward these subgroups are of growing 
importance due to the barriers this specific population faces. Designing, implementing, 
monitoring, researching, and improving models related to subpopulations are growing 
concerns (Coburn, 2016).  
ACO success depends heavily on provider behavior modification. To assure 
needed changes, social purpose and professional mastery should be used as two 
motivators alongside the financial incentives that are accessible with APM participation. 
Positive patient impact, community service, and an opportunity to become a more 
effective health care provider by working in a team environment are a few of the factors 
that can help stimulate needed changes for provider-related components of U.S. health 
care delivery (Phipps-Taylor & Shortell, 2016).  
Accountable Care Realizations 
MSSP ACOs have shown strong performance related to quality-of-care measures 
and have comprehensively yielded cost savings year over year since program inception. 
The longer an ACO participates in the MSSP, the more likely the ACO is to be successful 
due to significant time and efforts needed on redesign initiatives (Bleser et al., 2018). 
Shetty’s (2018) research argues that MSSP ACOs with four or more years of experience 
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in the program have a consistent association with reduced spending than peer ACOs with 
less experience.  
Some crucial strategies in reducing Medicare spending and improving care quality 
include efforts such as increasing providers’ awareness of costs, engaging beneficiaries 
(particularly those with complex care needs) in improving their own health, reducing 
avoidable hospitalizations, better managing SNF, home health, hospice and EoL 
initiatives, understanding BH and mental health needs, addressing SDOH, and utilizing 
technology to leverage information-sharing among the various participating health care 
providers (OIG, 2019).  
The DHHS’s Office of Inspector General (OIG) reported that most ACOs had 
instituted various strategies that have proven successful in lowering Medicare spending. 
Relatedly, the DHHS OIG suggested that CMS should conduct reviews to understand 
better the extent to which ACOs are improving quality and reducing spending. For 
example, care coordination is a critical component of most ACO’s success in reducing 
emergency department (ED) visits and hospital readmissions but sharing this information 
more widely, so an increased number of stakeholders become aware, is critical to yield 
even more spending reductions and quality improvements amongst ACOs that may need 
assistance (King, 2019).  
Another important pillar of ACO success is management involvement related to 
economies of scale. To increase the effective management of ACOs, care coordination is 
critical, but there must be adequate capital for Information Technology (IT) 
improvements to be used as a predictor of ACO performance (Lin, 2016). Proper IT 
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infrastructure as well as support for data mining, reporting, trending, analyses, and 
analytics are important factors for consideration.  
From its launch in 2012 through 2018, the MSSP grew to 10.5 million 
beneficiaries: a quarter of traditional (or FFS) Medicare. Rooke-Ley et al. (2019) 
reviewed that traditional Medicare, revitalized via the MSSP, saves 1.51% per 
beneficiary. The Medicare Political Action Committee (MedPAC) agreed, in effect, with 
these findings when they concluded that the MSSP saved one to two percent by the year 
2016. Some spillover can be accounted for, as well, adding another 0.57 percent to the 
overall savings the MSSP has over Medicare Advantage plans. 
CMS data shows that 2017 MSSP ACOs saved the federal government hundreds 
of millions of U.S. dollars. This number reinforces the fact that ACOs can yield financial 
savings if given enough ramp-up time. Also, of importance, is the need to further 
strengthen the program for longevity and viability (Sweeney, 2018). From 2013-2016, 
MSSP ACOs saved CMS an estimated $2.66 billion (Dobson et al., 2018).  
The Journal of the American Medical Association (JAMA) published a study that 
found upside only ACOs yielded a $287 million net savings in MSSP ACO performance 
year 2014. In like manner, the OIG reported in 2017 that ACOs lowered Medicare 
spending by $1 billion during the first three years of the MSSP. The National Association 
of ACOs (NAACOs) noted that time, resources, program predictability, experience, 
confidence, and some levels of success are all factors needed for ACOs to move toward 
two-sided ACO models. ACO-guru, current Aledade Chief Executive Officer (CEO) and 
former National Coordinator for Health Information Technology (HIT) in the Obama 
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Administration, Farzad Mostashari, M.D., said that the overarching goal of the MSSP 
should not be how many ACOs participate, but how successful those that do participate 
are in improving patient care. If providers are going to participate in ACOs, they must be 
doing something to add value to the system (Meltzer, 2018).  
Shetty (2018) conducted a retrospective cohort study of MSSP ACOs from 2012-
2016 using CMS Public Use File (PUF) data to review overall ACO spending, using a 
generalized estimating equation model. Resultantly, findings noted that ACOs who 
rendered less primary care services via specialists spent less per capita. The study showed 
that in order to reduce spending and perform optimally, ACOs should allow for no more 
than 35 to 40 percent of specialists to provide primary care services. The research yielded 
that MSSP ACOs with more than two years of experience in the program have lower cost 
implications than peer ACOs still in their first year. It is a suggested finding that 
participation for several consecutive years is essential for implementing and realizing the 
necessary clinical and administrative organizational structure to meet or exceed Medicare 
accountable care expectations. Further, MSSP ACOs with four or more years of 
consecutive participation show consistently lower expenditures, year over year.  
Accountable Care Evolution 
In late December 2018, CMS published a final rule for MSSP ACOs to further 
promote accountability and competition, changing the program's reference name to 
Pathways to Success. For the Medicare Trust Fund (MTF) to see the increased cost 
savings needed to ensure the longevity of Medicare entitlement for beneficiaries, there is 
an encouragement from the U.S. federal government for MSSP ACOs to transition to 
27 
 
enhanced risk more quickly, based upon performance. Starting in July 2019, MSSP 
ACOs will enter into one of the various tracks with CMS for at least a five-year contract 
term (Dealtry, 2019).  
Before the evolutionary Pathways to Success update to the MSSP, the program 
included three tracks that allowed ACOs to gradually gain experience (sometimes up to 
six years with no downside risk to the ACO). No downside risk to the ACO meant that 
CMS took on any financial losses that the ACO yielded. While this created a glidepath 
for the ACO, it did not mandate the fiduciary responsibility of the ACO to share in the 
losses (Leventhal & Landi, 2018). 
Pathways to Success is bold in its heightened steps toward quality health care, 
lower costs, increased competition, and beneficiary engagement. ACO program 
participation is encouraged, but advancement in the transition to value-based health care 
and market impact are critical components. As providers further themselves along the 
U.S. health care value continuum, expectations for positive outcome are rising (Frieden, 
2018).  
With the Pathways to Success update, Leventhal and Landi (2018) noted that 
CMS is steering away from upside-only models and taking the stand that ACOs should 
only have two (versus the aforementioned six) years to progress toward higher levels of 
shared financial risk-sharing with CMS. The change is partly because, as of 2019, only 
eighteen percent of MSSP ACOs were engaged in downside risk. Ultimately, and as the 
CMS administrator, Seema Verma, has made clear, upside only MSSP ACOs do not 
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generate enough financial savings and there is, essentially, no real incentive to improve 
outcomes and reduce overall health care costs. 
As only about 10% of clinicians take on significant levels of financial risk today 
in the MSSP, adoption is one of the biggest challenges of advanced APMs. The 
transformative path towards value-based U.S. health care is not evolving as quickly as is 
needed. The limited, yet sometimes complex nature of APMs and the difficulty in 
obtaining actionable, insightful data are just two of the challenges that providers face in 
their committed pursuit of ensuring health care value. The Pathways to Success initiative 
saw thirty-eight of its applicants apply for advanced APM status risk levels (Leventhal, 
2019). Providers interested in population health management relationships with 
accompanying financial risk may look to quantify the amount of risk they are willing to 
accept while implementing unnecessary service mitigation treatments. Meaning, 
providers should weigh the needs of services against the costs of taking on financial risk 
with a payer. This utility review may better show provider risk aversion behavior 
(Franklin, 2017).  
CMS Administrator, Seema Verma, noted that Medicare (and the associated 
MTF) is no longer able to support programmatic initiatives with flaccid incentives that do 
not deliver the right outcomes. CMS looks to make a significant impact on the overall 
health care, specifically Medicare, market. To do so, CMS will continue to appropriately 
raise the bar as the MSSP matures to accelerate overall performance (Frieden, 2018).  
As MSSP ACOs have expansion goals, there are various recommendations to 
ensure advancement of the APMs and effectiveness of accountable care renderings. One 
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such recommendation is related to better understanding the education and professional 
backgrounds of organizational leaders and essential leadership skills required for 
representing diverse population health management needs (Cornell, 2019). Another 
recommendation is that of considering the relationship between patient satisfaction, 
engagement, and financial performance (Pugh, 2016). Additionally, the best methods of 
ACO beneficiary assignment to remain competitive and economically equitable as well 
as more balanced risk levels and more attractive incentives are also considerations for 
future research (Racca, 2019).  
Many positive outcomes of properly implemented ACOs exist while there are 
numerous open items related to understanding proper management. One would be remiss 
to not mention some of the ethical concerns that arise when ACOs are studied. Westling 
(2015) recalled the need for compatible reimbursement models; ensuring one uniform, 
proper standard of care; balancing patient choice with financial incentives, respectful 
disagreement on best practices, meeting ACO metrics versus evidence-based measures, 
as well as ensuring proper resources for preventive and reactive services as potential 
conflicts of ethical interest. ACO administrators and clinicians must keep these thoughts 
in mind when developing initiatives and planning for resources such as people, processes, 
and technology. Westling’s research identified several major ethical issues that fell under 
biomedical principal domains such as justice, autonomy, beneficence, and non-
maleficence. The research method Westling used was that of semi-structured, open-ended 
surveys. The overarching ethical issues included (a) under treatment due to financial 
reasons, (b) breaches of patient confidentiality, (c) lack of financial disclosures and (d) 
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overuse of practice guidelines. The findings were conflicting, but ultimately found that 
most providers will do what is in their patient's best interest. The only finding with a 
potential mitigation effect was that of shifting resources to be prevention focused. 
Alibrahim (2017) wrote on the importance of continuous evaluation and review of 
initiatives as the U.S. health care market evolves around regulations, antitrust, privacy 
and other related matters. The market’s ever-changing dynamics impact the powers, 
players, behaviors, and outcomes of ACOs. Provider capacity and service options are 
differentiating factors that can be leveraged to tip the competitive balance of ACOs. Case 
(2015) affirmed the need for health policy and delivery education programs for clinicians 
and administrators to improve their engagement levels and generate ideas for achieving 
efficient high-quality, lower cost U.S. health care.  
Accountable Care Total Savings/Losses, Quality Score and Total Assigned 
Beneficiaries 
Falk (2016) examined the 2014 performance data of Track 1 MSSP ACOs, using 
a quantitative analysis. The research findings included that ACOs further along in the 
contractual continuum of MSSP participation were more likely than younger, less mature 
ACOs to achieve savings; due partially to the learning curve, but also due to realized 
returns on initial investments in care coordination and preventative care initiatives. Falk 
(2016) noted there were numerous correlated data elements that showed statistical 
significance as it relates to overall success (generating savings) of the ACO, but there is 
however, still a need for additional research on future years’ ACO data to note the 
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relationship that MSSP ACO participation can have on overarching costs and quality as it 
relates to the beneficiary (or managed population) pool. 
Lin (2016) reviewed 2012, 2013, 2014 and 2015 MSSP ACO cohorts’ 
performance. The methodology used was quantitative analysis of secondary data using 
multiple logistic and linear regressions. The study was a survey with 61 ACO 
executive/manager respondents yielding various responses about their respective ACO’s 
performance and related perceptions of hospital involvement, degree of information 
technology adoption and usage as well as integration.  
Noting the current lack of adequate research studies and information related to 
current MSSP ACO performance, specifically germane to beneficiaries, cost, and quality; 
there is a need for the review of the 2018 performance year MSSPACOs as it relates 
particularly to Generated Total Savings/Losses, Quality Score and Total Assigned 
Beneficiaries.  
Definitions 
Accountable Care Organization (ACO): A legal entity formed by one or more 
ACO participants (Title 42 – Public Health, 2018). 
ACO participant: An entity enrolled in Medicare that composes an ACO (Title 42 
– Public Health, 2018). 
Assignable beneficiary: A Medicare FFS beneficiary who, within a certain one-
year period, sought primary health care services from a Medicare enrolled Doctor of 
Medicine (M.D.) or Doctor of Osteopathy (D.O.; Title 42 – Public Health, 2018). 
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Assignment: A CMS operational process of noting previous primary health care 
services from an ACO participant to appropriately designate a general beneficiary 
responsibility upon participant for a set performance year (Title 42 – Public Health, 
2018). 
Assignment window: The one-year period whereby beneficiaries are assigned to 
an ACO. Medicare FFS Beneficiary is a person who is enrolled in traditional Medicare 
(not a Medicare Advantage plan) for parts A and B (Title 42 – Public Health, 2018). 
(Gross) Generated losses: Total losses (measured as Benchmark Minus Assigned 
Expenditures, from first to last dollar) ACOs in Track 2, Track 3, or the Track 1+ Model 
whose losses rate equaled or exceeded their MLR. This amount does not account for the 
application of the ACO’s final sharing rate based on quality performance (for Track 2 or 
3 ACOs) or the loss sharing limit (CMS, 2020). 
(Gross) Generated savings: Total savings (measured as Benchmark Minus 
Expenditures, from first to last dollar) for ACOs whose savings rate equaled or exceeded 
their MSR. This amount does not account for the application of the ACO’s final sharing 
rate based on quality performance, reduction due to sequestration, application of 
performance payment limit or repayment of advance payments (CMS, 2020). 
Medical loss ratio (MLR): Money spent on premium dollars versus that spent on 
overhead activities. If an insurer uses eighty percent of premium dollars to pay claims 
and ensure quality improvement activities, the insurer is said to have a MLR of eighty 
percent if they spend the remaining twenty percent on overhead. The ACA set varying 
MLRs in different markets (healthcare.gov, 2020).  
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Minimum savings rate (MSR): A respective percentage of an ACO’s historical 
benchmark, updated and calculated based on the population size of the assigned 
beneficiary pool (healthcare.gov, 2020).  
Medicare Shared Savings Program (Shared Savings Program) One-Sided Model: 
One whereby the participating ACO shares the savings with the CMS program if certain 
requirements are met. This model does not create liability for the ACO to share in any 
financial losses (Title 42 – Public Health, 2018). 
Medicare Shared Savings Program (Shared Savings Program) Two-Sided Model: 
one whereby the participating ACO shares in any potential savings and is also liable for 
sharing in any potential financial losses (Title 42 – Public Health, 2018). 
Performance year and reporting period: Generally, the 12 months beginning on 
the first of January each year, unless otherwise noted (Title 42 – Public Health, 2018).  
Quality measures: Assess the quality of care that an ACO renders, inclusive of 
clinical outcomes (Title 42 – Public Health, 2018).  
Quality score: In Performance Year 1 of an ACO’s first agreement period, the 
quality score is 100% if all measures were completely reported and less than 100% if one 
or more measures were not completely reported. Beyond Performance Year 1 of an 
ACO’s first agreement period, the quality score will be determined not only by whether 
all measures were completely reported but also on their performance against established 
benchmarks and on quality improvement. For ACOs determined to have been affected by 
a natural disaster, the quality score is the higher of the ACO's calculated initial quality 
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score or the national mean quality score across all Shared Savings Program ACOs who 
met the quality performance standard (CMS, 2020). 
Total assigned beneficiaries: The total number of beneficiaries assigned to an 
ACO in a particular performance year (CMS, 2020).  
Assumptions 
The aspects of this study believed to be true were that the participating ACOs 
understand what population health is, what their basic principles are, what the goals of 
the MSSP are and how to ensure objectives are met. Additionally, it is assumptive that 
each ACO knows the MSSP ACO performance rules, guidelines, and factors that impact 
advanced APMs. These assumptions are of critical importance as ACOs participate in the 
MSSP and are necessary in the context of the study due to the need to manage an entire 
population (at least five thousand attributed, assigned Medicare beneficiaries). Moreover, 
it is assumed that MSSP ACOs know their organization signed up to be accountable for 
the overall care of their patient population, must coordinate care with various health care 
teams, invest in infrastructure, and work toward redesigning health care to ensure highly 
efficient and quality service delivery (Physicians Advocacy Institute, 2020).  
Scope and Delimitations 
The scope of the study was inclusive of 2018 MSSP ACO results related to 
Generated Total Savings/Losses, Quality Score, and Total Assigned Beneficiaries. The 
specific aspects of the research problem addressed in the study were the costs, quality and 
total assigned beneficiaries of 2018 MSSP ACO participants. The specific focus chosen 
was because 2018 was the most recent publicly shared data file at the time this study was 
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initiated. As ACOs participate in the more recent years’ MSSPs, and as years’ worth of 
value-based health care progresses in the U.S., the understanding of population health 
should be relatively mature, the organizations should be evolved, and it is arguable that 
transformation should be able to be properly managed in terms of the people, processes, 
and technology required.  
The boundaries of the study included MSSP ACO participants that have served 
various evaluation and management (E&M) services to at least 5,000 Medicare FFS 
beneficiaries and have a contract with CMS for at least three years. MSSP ACOs could 
include ACO professionals (physicians, physician assistants, or nurses) in group 
arrangements, networks of individual practices working together, partnerships or joint 
ventures, hospitals, FQHCs, and/or Rural Health Clinics (RHCs). The Medicare 
beneficiaries are attributed to the MSSP ACOs through a prospective methodology based 
on historical claims data, actual plural utilization during the performance year or 
preliminary assignment, or voluntary alignment (Physicians Advocacy Institute, 2020). 
This study did not include products or populations that are outside of MSSP ACO 
parameters such as commercial, Medicare Advantage (M.A.), Medicaid, CHIP, ACA 
Individual Exchange, and/or Veterans Affairs (V.A.) health plans and managed care 
organizations.  
Theories related to this study, but were not fully investigated herein include, but 
are not limited to, the ACO Logic Model, Resource Dependency Theory, Structural 
Contingency Theory and Transaction Cost Economics (Palazzolo, 2015). The potential 
for generalizability was considered, but well understood that Medicare beneficiaries are 
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not all treated equitably in terms of accountable care service renderings and outcomes-
based measurement amongst different providers, across various programs in disparate 
geographies.  
The limitations of this work included data, analysis, and trending reports that are 
provided by the U.S. federal government and engaged, interested or participating 
organizations of MSSPs for the years of implementation, participation, and reporting. 
Therefore, the findings in terms of the relationship between Quality Score, Generated 
Total Savings/Losses and Total Assigned Beneficiaries cannot be representative of the 
entire U.S. health care system nor even all the Medicare-eligible population (as a large 
percentage of beneficiaries participate in a M.A. plan and some participate in none) and 
does not compare MSSP ACOs to non MSSPs ACO that may also be generating a higher 
value for the same variables of this study. While the Medicare FFS program showed that 
certain MSSP ACOs have generated savings for that specific sector of the population, it 
does not negate the fact that the entire system’s cost could still be increasing, and quality 
could still be declining.  
The challenges that arise when one attempts to review a relatively new program in 
a dynamic environment in an evolving, ever-changing system are that things do not 
remain static. It is difficult to ensure sound statistical analysis when there are frequent 
changes, year-over-year to the quality measures, or the cost-savings factors. Systematic 
and technical adjustments, as well as re-alignment, must be made by providers that may 
cause indifferent results. It is arduous to measure certain quality metrics when there are 
so many outlying issues that can affect the result. One must review data and reasoning 
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but understand there are retrospective changes that occur as well as arguments to a 
methodology that make sense in the space that must be considered.  
The barriers one stands against when reviewing MSSP ACO quality measure data 
is the difficulty (or near impossibility) with extracting the effects that other Medicare 
changes and regulations have on the MSSP. For example, changes in Medicare rules 
regarding inpatient days, bundled payments for services such as total knee replacements, 
and other advents geared toward ensuring proper care across all provider types can and 
will very likely have a compounding, comprehensive effect on other initiatives being 
studied, such as MSSP ACOs. This is beyond the scope of this work but is a means for 
future study.  
Significance, Summary, and Conclusions 
This study contributed to a better understanding of the potential relationship 
between Generated Total Savings/Losses, Quality Score and Total Assigned 
Beneficiaries within 2018 MSSP ACOs. A scholarly review of the public use data file for 
2018 validated Medicare Generated Total Savings/Losses and Quality Score advances as 
it relates to Total Assigned Beneficiaries (CMS, 2018). This is meaningful to the system 
in a multitude of ways. As previously reviewed in this study and as Falk (2016) noted, 
research performed on future years’ MSSP ACO data (such as performance year 2018) is 
needed to relay the relationship amongst variables such as those studied in this work.  
The bequest to the health services administration discipline, and the practice of 
health care in general, that this study will make is presenting to the reader the realities of 
statistically significant relationships among Quality Score, Generated Total 
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Savings/Losses and Total Assigned Beneficiaries in a specific MSSP ACO performance 
year. The relationship is important to understand in noting how organized, accountable 
health care, rendered in a quality-oriented, cost-aware state may qualitatively be 
considered a foremost option for overall medical and administrative cost savings 
concurrently boosting quality metrics, specifically in the Medicare space; replicable in 
other sectors of the system, but may or may not reflect same in a quantitative way. The 
research looks to support the professional practice of health care, in general, and 
demonstrate practical application by presenting select 2018 performance year data to 
review if MSSP ACOs should be considered an avenue of which can be utilized to reach 
the overarching U.S. health care system goals of achieving better care for individuals and 
better health for populations while lowering the growth in expenditures (National 
Association of ACOs, 2018). 
MSSP ACOs that have shown success in meeting quality indicator benchmarks 
and cost savings have a series of strategies that they have followed, including, but not 
limited to care management, transitions of care administration, varying use of health IT, 
and improved processes (Mostashari & Broome, 2016). It is significantly relevant that the 
MSSP arrangement launched under the ACA to reduce spending and improve quality of 
care, among other objectives, is working. ACOs have resulted in favorable Medicare cost 
and quality performance (Livingston, 2017). The remaining question for enveloping U.S. 
health care lies in just how deep, broad, and far-reaching the effects of MSSP ACOs can 
be to the systemic structure. Interested parties look to better understand how the 
organizations will lead to positive social change for health care stakeholders of all kinds: 
39 
 
patients, providers, public payers, private constituents, policymakers, researchers, and the 
like. If MSSP ACOs can continue to decrease health care costs while concurrently 
increasing quality for managed populations, there is a compelling argument for their 
staying power in the U.S. health care system. If able to maintain momentum and prove 
transformative, MSSP ACOs could forever change the health care landscape. 
Section 1 provided the problem statement, purpose of the study, research 
questions and related hypotheses, theoretical foundation, nature of the study, literature 
review, definitions assumptions, scope, delimitations, and significance. Section 2 will 
review the research design and rationale, analysis methodologies, threats to validity and 
ethical procedures. Section 2 will review the research design and rationale, methodology, 
threats to validity, as well as ethical procedures. 
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Section 2: Research Design and Data Collection 
The purpose of this quantitative study was to note the statistically significant 
relationship between Quality Score, Generated Total Savings/Losses, and Total Assigned 
Beneficiaries for MSSP ACO participants in the 2018 performance year. The literature 
review yielded findings that MSSP ACOs are a viable option for health administrators to 
reach systemic goals due to their effect on cost and quality; they can not only save the 
federal government billions of dollars as the years progress and initiatives become more 
innovative and collaborative, but also ensure care quality is enhanced (National 
Association of ACOs, 2018). The need for my study lay in noting whether MSSP ACOs 
can improve quality and costs savings to allow further expansion of ACOs by health 
administrators by reviewing the relationship between 2018 MSSP ACOs’ Quality Score, 
Generated Total Savings/Losses and Total Assigned Beneficiaries. 
The major sections of this chapter include Research Design and Rationale, 
Methodology (population, sampling, and instrumentation/operationalization), and Threats 
to Validity (including Ethical Procedures).  
Research Design and Rationale 
The study’s variables were Generated Total Savings/Losses, Quality Score and 
Total Assigned Beneficiaries. For Research Question 1, the independent (X, horizontal 
line) score, predictor variable was Quality Score and the dependent (Y, vertical line) 
score variable was Generated Total Savings/Losses. The independent and dependent 
variables were both scale variables; therefore, the analysis performed was a simple linear 
regression. For Research Question 2, the independent (X) variable was Total Assigned 
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Beneficiaries, and the dependent (Y) variable was Quality Score. The independent and 
dependent variables were both scale variables; therefore, the analysis performed was also 
a simple linear regression. 
The research design was nonexperimental using secondary data quantitative 
analysis. Nonexperimental design does not manipulate the variables studied; it is used in 
research when there are specific research questions or hypotheses about correlations 
amongst variables (Mehl et al., 2007). Nonexperimental design was applied to this study 
because I used a PUF, whereby the variables were studied, not manipulated in any way, 
and I hypothesized what the relationships were among the independent and dependent 
variables. The methodology of inquiry was a systematic review and strategic analysis of 
said publicly available secondary data for MSSP ACO participants in the 2018 
performance year. The connection of the research design to the research questions aligns 
as the secondary data allowed me to note the relationship between Quality Score to 
Generated Total Savings/Losses and Quality Score to Total Assigned Beneficiaries. 
The time constraint of this study was that the only ACO performance year to be 
studied was 2018. Only the 2018 MSSP ACO performance year was studied because it 
was the most current MSSP ACO PUF data shared at the time of doctoral study initiation 
and allowed me to review Quality Score, Generated Total Savings/Losses, and Total 
Assigned Beneficiaries data for the most recent year of MSSP ACO participation, at the 
time.  
Resource constraints consisted of the fact that the research only reviewed CMS 
MSSP ACO PUF data available via the internet on CMS’s website. Other sources of data 
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that could have been used in this study, but were not, include Medicare Hospital Compare 
Data, Agency for Healthcare Research and Quality (AHRQ) information, National 
Committee for Quality Assurance (NCQA) quality indicators, and other CMS as well as 
private payer ACO data.  
Additional factors that this study could have included, but did not, were whether 
MSSP ACOs were a part of other pay-for-performance, value-based, outcomes-based 
quality improvement, APM and/or cost savings initiatives with other payers for 
commercial, M.A. Medicaid, Children’s Health Insurance Program (CHIP), Exchange, 
V.A., or other lines of business.  
This study did not take into account whether the reviewed 2018 MSSP ACO 
participants engaged in any other CMS healthcare transformation efforts under 
accountable care (e.g., the Comprehensive End-Stage Renal Disease Care Model, the 
Medicare Health Care Quality Demonstration and the Vermont All-Payer ACO Model), 
episode-based payment initiatives (e.g., Bundled Payments for Care Improvement 
Initiative, Comprehensive Care for Joint Replacement Model and Oncology Care Model), 
nor primary care transformation (e.g., Comprehensive Primary Care Plus, Independence 
at Home Demonstration and Primary Care First Model).  
Also not accounted for in this study was whether 2018 MSSP ACO participants 
were a part of other CMS initiatives focused on the Medicaid and CHIP population (e.g., 
Medicaid Innovation Accelerator Program, Financial Alignment Initiative for Medicare-
Medicaid Enrollees, and Initiative to Reduce Avoidable Hospitalizations Among Nursing 
Facility Residents).  
43 
 
Initiatives to accelerate the development and testing of new payment and service 
delivery models (such as Accountable Health Communities Model, Artificial Intelligence 
Health Outcomes Challenge, CMS Innovation Center New Direction, Emergency Triage, 
Treat and Transport Model, Home Health Value-Based Purchasing Model, Maryland All-
Payer Model, Maryland Total Cost of Care Model, MA, Value-Base Insurance Design 
Model, Medicare Care Choices Model, Pennsylvania Rural Health Model, Regional 
Budget Payment Concept, Rural Community Hospital Demonstration, State Innovation 
Models Initiative and Value in Opioid Use Disorder Treatment Demonstration Program) 
were also not noted in this study. 
Initiatives to speed the adoption of best practices (such as the Health Care 
Payment Learning and Action Network, Hispanic Health Services Research Grant 
Program, Historically Black Colleges and Universities Research Grant Program, 
Medicare Diabetes Prevention Program Expanded Model, Million Hearts and Partnership 
for Patients) were not specifically reviewed in this study to note whether MSSP ACO 
participants partook in those efforts or not.  
The design choice of nonexperimental secondary data analysis, whereby CMS 
2018 MSSO ACP PUF data were reviewed to understand the relationship between 
Generated Total Savings/Losses, Quality Score and Total Assigned Beneficiaries for the 
participants in the 2018 performance year, was consistent with the need to advance 
knowledge of MSSP ACO overall performance in the most mature year since inception 
of the program to compare various metrics for correlations.  
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Generated Total Savings/Losses were the total savings or losses that the 
participating MSSP ACOs renders for their patient population; ultimately–whether the 
ACO spent less money than benchmarked in the performance year, or more. Quality 
score was originally measured as 100% if all measures were completely reported and less 
than 100% if one or more measures were not completely reported. Afterward, quality will 
be determined by whether measures were completely reported and the performance 
against established benchmarks and improvement efforts. Total Assigned Beneficiaries 
were the total number of Medicare beneficiaries that each ACO had attributed to the 
group.  
I used the CMS’s MSSP ACO 2018 Public Use Files as the source of data. At the 
time of writing, the information could be found on CMS’ website. 
Methodology 
Population 
The population included in this study were the 2018 MSSP ACO provider 
participants and their related managed beneficiary pool. As of the first day in January of 
the 2018 performance year, there were 561 ACOs (the most out of all performance years, 
2012 to current) in all fifty states plus Washington, DC, and Puerto Rico. The 10.5 
million assigned Medicare beneficiaries in the year 2018 was the second highest of all 
MSSP ACO performance years, 2012 to current. $983 million was the total earned shared 
savings (the most out of all performance years, 2012 to current). There was a reported 
93% average overall quality score (second highest to 2016’s and 2012/2013’s 95%). In 
the 2018 performance year, there were 171 physician-only ACOs (30%, 324 physicians, 
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hospitals and other facilities ACOs (58%), and 66 FQHCs/RHCs ACOs (12%). The 2018 
Medicare beneficiary demographic distribution was as follows: 
• ESRD – 81,397 (0.79%) 
• Disabled – 1,294,555 (12.64%) 
• Aged Dual – 688, 076 (6.72%) 
• Aged Non-Dual – 8,180, 954 (79.85%; CMS, 2019) 
Sampling and Sampling Procedures Used  
The population included the comprehensive MSSP ACO 2018 performance data 
set. The sample for sensitivity analysis was determined by a G*Power Analysis. The 
procedure used to collect the secondary quantitative data consisted of visiting the CMS’s 
MSSP ACO PUF government website (https://www.cms.gov/Research-Statistics-Data-
and-Systems/Downloadable-Public-Use-Files/SSPACO), clicking on the 2018 Shared 
Savings Program ACO interactive data set and opening the associated next page. Then, I 
exported the standard analytical data file into an Excel workbook. Once the Excel 
workbook was open, I filtered columns to only see column B (ACO_Name), column S 
(N_AB), column W (GenSaveLoss) and column AB (QualScore) to make the data set 
easier to analyze for the linear regressions that were performed. The dataset showed a 
total of 548 participating ACOs with associated variables. As noted earlier in this study, 
N_AB is the variable name for Total Assigned Beneficiaries, GenSaveLoss is the 
variable name for Generated Total Savings/Losses and QualScore is the variable name 
for Quality Score.  
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 As noted in this work, RQ1 asked, Is there a statistically significant relationship 
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare 
Shared Savings Program Accountable Care Organization participants? The null 
hypothesis for RQ1 stated there is no statistically significant relationship between the 
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings 
Program Accountable Care Organization participants. The alternative hypothesis for RQ1 
stated there is a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. RQ2 asked, Is there a statistically significant 
relationship between the Quality Score and Total Assigned Beneficiaries for 2018 
Medicare Shared Savings Program Accountable Care Organization participants? The null 
hypothesis for RQ2 stated there is no statistically significant relationship between the 
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings 
Program Accountable Care Organization participants. The alternative hypothesis for RQ2 
stated there is a statistically significant relationship between the Quality Score and Total 
Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care 
Organization participants. RQ1’s independent variable is Quality Score. RQ1’s 
dependent variable is Generated Total Savings/Losses. RQ2’s independent variable is 
Total Assigned Beneficiaries. RQ2’s dependent variable is Quality Score.  
 I ran a preliminary sensitivity analysis via G*Power (Version 3.1.9.6 for Mac OS 
X 10.7 to 10.15; 2 MB) software. This preliminary sensitivity analysis was run to better 
understand certain elements and the minimum sample size needed for the comprehensive 
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data analysis. The protocol of power analyses via G*Power included an F test, using the 
statistical test of linear multiple regression: fixed model, R2 deviation from zero. The type 
of power analysis was a priori, used to compute required sample size – given alpha, 
power and effect size. The input parameters determined a 0.15 effect size f2, 0.05 alpha 
err prob, 0.8 power (1-beta err prob), and the total number of predictors as 1. The output 
parameters determined an 8.2500000 noncentrality parameter, 4.0230170 critical F, 1 
numerator df, 53 denominator df, 55 total (minimum) sample size and 0.8050826 actual 
power.  
Instrumentation and Operationalization of Constructs 
This study used a published instrument developed by the CMS, with associated 
data published in 2019 and made publicly available on the CMS’ government website. 
The study reviewed the MSSP ACO 2018 performance year. This instrumentation was 
appropriate to the study because it was used to note the relationship between the variables 
chosen for review. Permission was not required from the developer (the CMS) because it 
was a U.S. government-supplied data file created for public consumption and use. 
However, an emailed permission letter (see Appendix) was exchanged between the CMS 
and scholar practitioner that confirms permission and use for this doctoral study. The 
reliability of the published instrument was high because it yielded the same results 
regardless of the researcher using the federally shared PUF data set. The validity of the 
published instrument has been argued by various interested parties due to the fact the data 
set cannot predict counterfactual scenarios. Specifically, it is hard to know what would 
have been spent on CMS covered benefits for the population served if ACOs did not exist 
48 
 
(LaPointe, 2017). This instrument was previously used in performance years 2012, 2013, 
2014, 2016, and 2017 with the same Medicare population, but with slightly different 
measures and modes of interpretation. The instrument is planned to be used in future 
performance years, as well.  
Operationalization 
 All variables in this study had numerical values. The operational definition of 
Total Assigned Beneficiaries, Quality Score and Generated Total Savings/Losses was 
noted earlier in this work. In summary, N_AB was the variable name for Total Assigned 
Beneficiaries, GenSaveLoss was the variable name for Generated Total Savings/Losses 
and QualScore was the variable name for Quality Score. The description of Total 
Assigned Beneficiaries is the total number of assigned beneficiaries in the performance 
year. The description of Generated Total Savings/Losses is total savings for ACOs whose 
savings rate equaled or exceeded their MSR or total losses for ACOs whose loss rate 
equaled or exceeded their MLR. The description of Quality Score varies depending on 
performance year and agreement period. In the initial performance year of an ACO’s first 
agreement period, the Quality Score is automatically 100% if all measures were 
completely reported and less than 100% if one or more measures were not completely 
reported. After the initial performance year of an ACO’s first agreement period, the 
Quality Score will be determined by whether all measures were completely reported as 
well as the ACO’s performance against established benchmarks and on quality 
improvement. There is assistance in quality scoring for ACOs affected by natural 
disasters. (CMS, 2020). 
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 As previously stated earlier in this study: 
• The IV for RQ1 was Quality Score 
• The DV for RQ1 was General Total Savings/Losses 
• The IV for RQ2 was Total Assigned Beneficiaries 
• The DV for RQ2 was Quality Score 
 CMS uses prospective and retrospective beneficiary assignment for Tracks 1 and 
2. CMS uses prospective beneficiary assignment only for Tracks 1+ and 3. If a 
beneficiary receives at least one service from a primary care provider within that ACO, 
the beneficiary is assigned via a two-step process. Additionally, in the 2018 performance 
year, beneficiaries could self-designate via voluntary alignment through MyMedicare.gov 
(CMS, 2020). The operational definitions of the variables were described in the Purpose 
of the Study section of this work.  
Data Analysis Plan 
 Software used for initial analysis of the data was G*Power. G*Power is a 
statistical software used to calculate data analyses and related powers. Additional 
software used was that of IBM’s Statistical Package for the Social Sciences (SPSS). IBM 
SPSS is a statistical package utilized for interactive analyses. The researcher performed 
an initial G*Power analysis to determine the minimum needed sample size and address 
the elements to be reviewed in the data set. Data cleaning and screening procedures were 
reviewed by a quantitative methodologist, as appropriate. As noted previously in this 
work, the first research question noted if there is a statistically significant relationship 
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare 
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Shared Savings Program Accountable Care Organization participants and the second 
research question noted if there is a statistically significant relationship between the 
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings 
Program Accountable Care Organization participants. 
The analysis plan was inclusive of statistical tests, procedures, rationale, and 
interpreted results. The statistical tests that were used to test the hypotheses included 
simple linear regression of scale variables and ANOVA Analysis. The procedures used to 
account for two different statistical analyses were appropriate because of the two research 
questions and their differing independent and dependent variables. There were no 
covariates nor confounding variables. Results were reported (key parameter estimates, 
confidence intervals or probability values, odds ratios, etc.) by using the SPSS software 
tool.  
Threats to Validity 
The threats to external validity could have been potential interaction effects and 
reactiveness of arrangements. For example, if MSSP ACO participants engaged in 
multiple value-based care efforts, each requiring different initiatives to be worked on 
with various benchmarks and scoring mechanisms, there could have been confusion as to 
when and where to allocate particular practice protocols; how to properly manage the 
practice from an administrative and clinical perspective and when/if to treat certain 
members differently based on their associated payer. In contrast, a MSSP ACO 
participant could have been managing value-based care efforts for an attributed, assigned 
population and providing FFS health care needs. At the same time, though, if all patients 
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were treated with equitable health care consistencies in mind, providers might have 
reacted differently when rendering care to a FFS patient versus that of an outcomes-based 
one. This phenomenon of FFS volume versus value-based care provision could have 
negative or positive implications on the overall total patient population that the MSSP 
ACO provider participant oversaw. It is important to recognize the external threats in this 
study because although MSSP ACO participation was studied as a move in the right 
direction toward value-based health care in the U.S., there remains the above-stated 
extraneous factors that convolute that notion. 
The study’s threats to internal validity may have included program participation 
maturity, experimental mortality, and selection interaction. For example, if a MSSP ACO 
participant was aware of their participation requirements, understood the quality 
indicators and shared savings (cost) guidelines, but for whatever reason were not aligning 
with the organizational evolution, transformation, and reengineering required to meet 
value-based care needs, there may have existed a discord with the intent of the program. 
The more time that a provider remains participating in a MSSP ACO, the more mature 
the opportunity for advancement along the continuum. However, if practice 
administration and clinical refinement were not occurring and sophistication was lacking, 
therein could lie a problem with the move towards value-based health care. There could 
also have been an issue with providers not owning enough of the risk in their 
performance-based contractual agreement; meaning, there was not enough provider 
support as the practitioner did not have financial consequences as it relates to cost and 




This study used CMS MSSP ACO PUF data. Public use files are allowed by the 
CMS to be used where and when appropriate, by any public interested party. The 
researcher, however, did submit an electronic mail communication whereby permission 
was granted from the CMS for the researcher to use PUF data, noting that the public can 
utilize it for various purposes (inclusive of doctoral studies such as this). There will be no 
human participant (in this case, for example, Medicare beneficiaries nor MSSP ACO 
participating providers) specific detail provided in the PUF. There were no institutional 
permissions that needed to be granted to use the CMS’ MSSP ACO PUF data, thus none 
were obtained.  
Ethical concerns as it relates to recruitment materials and processes were not 
applicable at the person/member level for this study. From a business perspective, the 
MSSP ACO participating provider groups agreed in their CMS contract to publish their 
entity and performance information as it relates to the scores and benchmarks for their 
MSSP ACO participation in the applicable performance year (CMS, 2019). As the MSSP 
ACO participants had a contract in place, at the time, with CMS to relay the guidelines 
for participation in the program, there were no ethical concerns in this study related to 
data collection regarding MSSP ACO participants refusing to participate or requesting 
early withdrawal. 
The study data were taken from a federal government source, published for 
utilization by interested parties as a “Public Use File” posted on the CMS website. 
Although the data are public, permission to gain access to the secondary data set and 
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subsequent use in doctoral research was obtained from CMS. See Appendix A: 
Permission to Use CMS MSSP ACO PUF data. The public data used for this study were 
found and remains archived on the CMS website where the PUF data sets are housed. 
The data did not contain any sensitive or non-public information at the time of use. The 
CMS are the stewards of the data that was used in this secondary data analysis doctoral 
study. 
In terms of ethical implications, this study had no understood entanglements. The 
researcher used a public use file for the data analysis and received permission to use from 
the source. Secondly, the matter of privacy or confidentiality was overruled when it came 
to participating provider groups because each participant was fully aware of and agreed 
to allow their performance to be publicly available at the time. Insofar as Medicare 
beneficiary-specific detail, that remained privy to the data collection mechanism that 
CMS used to collect MSSP ACO details; not available via the PUF utilized for this study.  
Summary 
The research design of this study was non-experimental using secondary data 
quantitative analysis of a CMS public use data file. The methodology of inquiry consisted 
of a systematic review and strategic analysis of said publicly available secondary data for 
MSSP ACO participants in the 2018 performance year. The study noted that the 2018 
MSSP ACO performance year had the most participants, the most total earned shared 
savings and the second highest average overall Quality Score of all years, to date 
(Centers for Medicare & Medicaid Services, 2019).  
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Sullivan and Feore (2018) noted a recent analysis finding that the more 
experience MSSP ACOs have, the more likely they are to generate savings. The longer 
individual ACOs participate in the MSSP, the broader the shift away from FFS models 
become. Year-over-year participation in a MSSP ACO allows for more experience with 
population health management, creation, and implementation of data infrastructure(s), 
and changing behavior to render positive financial results and quality indicators.  
Section 2 provided the research design and rationale, analysis methodologies, 
threats to validity and ethical procedures. Section 3 will review the collection of 
secondary data.  
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Section 3: Presentation of the Results and Findings 
The purpose of this quantitative study, and a differentiator from others published, 
was to note the statistically significant relationship between quality and costs as well as 
the statistically significant relationship between quality and the assigned beneficiaries for 
MSSP ACO participants in the 2018 performance year. The literature review revealed 
that MSSP ACOs are a viable option for health administrators to reach systemic goals 
due to their effect on cost and quality; they can not only save the federal government, 
revenue via taxpayers, billions of dollars as years progress and initiatives become more 
innovative and collaborative, but also ensure care quality is enhanced (National 
Association of ACOs, 2018). This study was needed to determine whether MSSP ACOs 
can improve quality and costs savings as it relates to assigned beneficiaries to allow 
further expansion of ACOs by health administrators.  
The research questions and hypotheses, as presented previously in this study, are 
noted below:  
RQ1: Is there a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants?  
H01: There is no statistically significant relationship between the Quality Score 
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
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H11: There is a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
RQ2: Is there a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants? 
H02: There is no statistically significant relationship between the Quality Score 
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
H12: There is a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants. 
RQ1’s independent variable is Quality Score. RQ1’s dependent variable is 
Generated Total Savings/Losses. RQ2’s independent variable is Total Assigned 
Beneficiaries. RQ2’s dependent variable is Quality Score.  
Generated total savings are the gross total savings for ACOs whose savings rates 
were equal to or less than their MSR. Generated total losses are the gross total losses for 
Track 2 and 3 ACOs whose savings rates were less than or equal to their MLR. ACO 
Tracks (inclusive of 2, starting in 2012 and 3, starting in 2016) vary in financial 
structures, beneficiaries, data and quality reporting requirements, compliance, and 
waivers. Quality Score was 100% in the ACO’s first agreement period if all measures 
were completely reported and less than 100% if one or more measures were not 
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completely reported. Medicare requires ACOs to report the quality measures, which are 
composed of 33 nationally recognized measurements in four categories (i.e., patient 
experience, care coordination/patient safety, and preventative health) and five different 
at-risk populations. Afterward, the Quality Score is determined by whether measures 
were completed reported or not and on the ACO’s performance against certain quality 
improvement initiatives and established benchmarks (CMS, 2018).  
This section reviews the data collection process using a secondary data set, data 
analysis results, and the summary of findings.  
Data Collection of Secondary Data Set 
I used the CMS’s 2018 Medicare Shared Savings Program Accountable Care 
Organizations Public Use File data (and associated dictionary) as the data source for this 
study. The files were found on the CMS site (https://www.cms.gov/Research-Statistics-
Data-and-Systems/Downloadable-Public-Use-Files/SSPACO/index.html). The data 
document was titled 
“2018_Shared_Savings_Program_SSP_Accountable_Care_Organizations_ACO_PUF.” 
The dictionary document was titled “Dictionary.ACO.SSP.PUF.2018” (CMS, 2018).  
The time frame for data collection was inclusive of the 2018 performance year. I 
did not have to complete any recruitment efforts nor be concerned with response rates as 
the secondary data set was managed by the CMS’ 2018 MSSP ACO participants. There 
were no discrepancies in using the secondary data set from the plan presented in Section 
2 of this work.  
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The baseline descriptive and demographic characteristics of the sample included 
Generated Total Savings/Losses (noted as GenSaveLoss in the dataset), Quality Score 
(noted as QualScore in the dataset) and Total Assigned Beneficiaries (noted as N_AB in 
the dataset). The sample represented the population of interest having included 548 
participating MSSP ACOs in the 2018 MSSP ACO performance year.  
The statistical assessment used to test the hypotheses for both RQs was simple 
linear regression of scale variables. The procedures used to account for two different 
statistical analyses were appropriate because of the two research questions and their 
differing independent and dependent variables. There was no basic univariate analysis, 
covariates, nor confounding variables. Once SPSS was opened, I used the analyze option 
to review descriptive statistics then frequencies to create tables in the software, presented 
herein.  
The Results 
Descriptive statistics and related data visualizations were reviewed for the three 
variables included in RQ1 and RQ2 with a total population of 548. The Mean (average) 
of Quality Score was 0.929064. The mean of Total Assigned Beneficiaries was 
18,424.95. The mean of Generated Total Savings/Losses ($) was 2,850,592.38. These 
statistics of the average participating 2018 MSSP ACO note a Quality Score of nearly 1, 
Total Assigned Beneficiaries of just over 18,000 and Generated Total Savings of almost 
$3 million. The findings show the analyst and interested parties that the 2018 MSSP 
ACO participating providers were, on average, mostly high quality with shared savings, 
managing nearly 20,000 beneficiaries. The relevance lies in the fact that one could note 
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overarchingly that 2018 MSSP ACO participating providers rendered high quality care in 
a cost-effective manner for many beneficiaries.  
The median for Quality Score was 0.937650. The median for Total Assigned 
Beneficiaries was 11,688.50. The median for Generated Total Savings/Losses was 0.00. 
The findings show the analyst and interested parties that middle-of-the-road 2018 MSSP 
ACO participating providers were mostly high quality with no shared savings, managing 
nearly 12,000 beneficiaries. The relevance lies in the fact that one could note 
overarchingly that between the highest and the lowest, the middle-performing 2018 
MSSP ACO participating providers rendered high quality care for thousands of 
beneficiaries, but not with cost savings.  
The mode for Quality Score was 1.0000. The mode for Total Assigned 
Beneficiaries was 5,230. The Mode for Generated Total Savings/Losses was 0. These 
statistics note that most participating 2018 MSSP ACOs had a Quality Score of 1, 
managed a Total Assigned Beneficiary pool of just over 5,000 and did not have any 
Generated Total Savings or Losses.  
 The standard deviation of Quality Score was 0.0688419. The standard deviation 
of Total Assigned Beneficiaries was 18,572.682. The standard deviation of Generated 
Total Savings/Losses ($) was 9,676,813.542. Standard deviation shows how dispersed the 
data is related to the mean (average). The lower the standard deviation, data is more 
clustered around the mean. The higher the standard deviation, data is more spread out. A 
Quality Score standard deviation at nearly 0.07 has data close to the mean. A Total 
Assigned Beneficiaries standard deviation over 18,000 means data is not close to the 
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mean. A Generated Total Savings/Losses standard deviation of almost 10 million means 
data is not at all close to the mean. Therefore, most ACOs have similar Quality Score, but 
Total Assigned Beneficiaries and Generated Total Savings/Losses are scattered.  
The skewness of Quality Score was -2.037. The skewness of Total Assigned 
Beneficiaries was 3.079. The skewness of Generated Total Savings/Losses was 3.666. 
Skewness measures the variable deviation of normal distribution from probability 
distribution. Skewness can be used to describe the degree of asymmetry. In this study, the 
variables with a positive skew greater than zero were Total Assigned Beneficiaries and 
Generated Total Savings/Losses; the mean is greater than the medium.  
The standard error of skewness for Quality Score was 0.104. The standard error of 
skewness for Total Assigned Beneficiaries was 0.104. The standard error of skewness for 
Generated Total Savings/Losses was 0.104. Standard error of skewness can be used to 
test normality. In this study, normality can be accepted because the findings are between -
2 and +2; meaning, the descriptive statistics are within reason.  
The kurtosis of Quality Score was 9.083. The kurtosis of Total Assigned 
Beneficiaries was 12.068. The kurtosis of Generated Total Savings/Losses was 34.690. 
Kurtosis measures the extent of outliers and can be used to describe a distribution. Higher 
kurtosis indicates less likelihood of deviations. Normal distributions have a kurtosis value 
of zero. Positive kurtosis indicates more outliers. Negative kurtosis indicates less outliers. 
The findings of this study note there are some outliers, but seemingly not too extreme.  
Data sets with higher kurtosis oftentimes have outliers whereas data sets with 
lower Kurtosis tend to lack outliers. In this study, the Quality Score and Total Assigned 
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Beneficiaries variables were lower than the Generated Total Savings/Losses variable; 
meaning, the two former mentioned variables had less outlier likelihood.  
The standard error of kurtosis for Quality Score was 0.208. The standard error of 
kurtosis for Total Assigned Beneficiaries was 0.208. The standard error of kurtosis for 
Generated Total Savings/Losses was 0.208. Standard error of kurtosis can be used to test 
normality. In this study, normality can be accepted because the findings are between -2 
and +2; meaning, the descriptive statistics are within reason. 
The minimum for Quality Score was 0.4545. The minimum for Total Assigned 
Beneficiaries was 605. The minimum for Generated Total Savings/Losses was -
45,126,888 (losses of estimated $45 million). These statistics note that the minimum 
Quality Score for participating 2018 MSSP ACOs was less than 0.46, the least number of 
Total Assigned Beneficiaries managed was 605 and the least Generated Total Savings 
was negative; the most Generated Total Losses was $45 million.  
The maximum for Quality Score was 1.0. The maximum for Total Assigned 
Beneficiaries was 137,516. The maximum for Generated Total Savings/Losses ($) was 
112,523,299. These statistics note that the maximum Quality Score for participating 2018 
MSSP ACOs was 1, the highest number of Total Assigned Beneficiaries managed was 




Table 4  
Variable Statistics 





N Valid 548 548 548 
Missing 0 0 0 
Mean .929064 18424.95 2850592.38 
Median .937650 11688.50 .00 
Mode 1.0000 5230a 0 
Std. Deviation .0688419 18572.682 9676813.542 
Skewness -2.037 3.079 3.666 
Std. Error of Skewness .104 .104 .104 
Kurtosis 9.083 12.068 34.690 
Std. Error of Kurtosis .208 .208 .208 
Minimum .4545 605 -45126888 




Figure 1  
Quality Score Statistics 
 
This chart shows the mean Quality Score as 0.9291. Most of the participating 
MSSP ACOs in the 2018 performance year had a Quality Score of 1. The minimum score 
was 0.4545. The maximum score was 1.  
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Figure 2  
Total Assigned Beneficiaries Statistics 
 
This chart shows the mean Total Assigned Beneficiaries at 18,435. Most of the 
participating MSSP ACOs in the 2018 performance year managed 5,230 Total Assigned 





Figure 3  
Generated Total Savings/Losses Statistics 
 
This chart shows the mean Generated Total Savings/Losses at $2,850,592. Most 
of the participating MSSP ACOs in the 2018 performance year saved CMS $0. The 
minimum savings was -$45,126,888; these were losses. The maximum savings was 
$112,523,299.  
After descriptive statistics were reviewed for the two variables included in RQ1 
and the two variables included in RQ2, the researcher/analyst used SPSS to run a simple 
linear regression analysis (SPSS: Analyze à Regression à Linear) for the research 
questions with the accompanying statistics options chosen in SPSS: Estimates, 
Confidence Intervals at 95%, Model Fit, R Squared change, and Descriptive Statistics. 
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Additionally, the plots option was chosen in SPSS to include histogram and normal 
probability plot.  
RQ1: Is there a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants?  
H01: There is no statistically significant relationship between the Quality Score 
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants.  
H11: There is a statistically significant relationship between the Quality Score and 
Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
After analyzing the dataset, the null hypothesis was accepted and shown to be the 
true hypothesis. The analysis yielded results showing no statistically significant 
relationship between Quality Score and Generated Total Savings/Losses for 2018 
Medicare Shared Savings Program Accountable Care Organization provider participants. 
The data depicted a very low likelihood that their Quality Score impacted Generated 
Total Savings (or) Losses in 2018 MSSP ACOs. Meaning, if Quality Score changed (up 
or down), Generated Total Savings/Losses did not vary tremendously. In summary, 
Quality Score was not a predictor of Generated Total Savings/Losses in the 2018 
performance year. 
The variables for RQ1 were Quality Score and General Total Savings/Losses; 
both scale variables. Quality Score was the independent predictor (constant) variable 
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shown on the horizontal X-axis. General Total Savings/Losses was the dependent 
variable displayed on the vertical Y-axis. Dependent and independent variables were 
updated for SPSS analysis, as described herein.  
The variable statistics ran show that the mean Quality Score was 0.93 and the 
mean of Generated Total Savings/Losses was $2,850,592. The average participating 
MSSP ACO in the 2018 performance year had a Quality Score of 0.93 and saved CMS 
$2,850,592. The dataset used a sample size of 548 MSSP ACO participants.  
The Pearson correlation results for Quality Score and Generated Total 
Savings/Losses were 1.000 and -0.036. This depicts an estimated 3.5% correlation 
between Generated Total Savings/Losses being dependent on Quality Score. The data 
shows that there is a very low likelihood that Generated Total Savings or Losses in 2018 
MSSP ACOs were impacted by their Quality Score.  
The significance (one-tailed) for Quality Score and Generated Total 
Savings/Losses was 0.199. The difference between the observations is not statistically 
significant because it is more than 0.05. Therefore, the null hypothesis is accepted. The 
results for RQ1 (is there a statistically significant relationship between the Quality Score 
and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants?) were that there was not a statistically 
significant relationship between Quality Score and Generated Total Savings/Losses for 
2018 Medicare Shared Savings Program Accountable Care Organization participants. 
The null hypothesis (there is no statistically significant relationship between the Quality 
Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings Program 
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Accountable Care Organization participants) was accepted. The alternative hypothesis 
(there is a statistically significant relationship between the Quality Score and Generated 
Total Savings/Losses for 2018 Medicare Shared Savings Program Accountable Care 
Organization participants) was rejected.  
The model summaries included R of 0.036, R square of 0.001, adjusted R square 
of -0.001 (nearly 100% of the model is not explained), standard error of the estimate at 
9,679,330.245, R square change of 0.001, F change at 0.716, df1 at 1 and df2 at 546 with 
change statistics of significant F change at 0.398. The 0.001 R square at 1/10 (1%) 
explains the variation as very low. If the Quality Score changes (up or down), Generated 
Total Savings/Losses does not vary tremendously; thus, the statistical significance is low. 
In summary, the dataset shows that Quality Score is not a predictor of Generated Total 
Savings/Losses. 
ANOVA analysis showed regression sum of square as 67,043,058,040,096.000. 
Regression sum of square depicts how well a regression model represents the data being 
modeled. One as high as this means the regression model does not fit the data well. 
ANOVA analysis showed residual sum of square as 51,154,430,963,240,432.000 with a 
total of 51,221,474,021,280,528.000. Residual sum of square measures modeling error 
variation. One as high as this means the regression model poorly explains the data. The 
regression mean square was 67,043,058,040,096.000; meaning this regression is not 
statistically significant. The residual mean square was 93,689,433,998,608.840; meaning 
the residual is not statistically significant. The F was 0.716 and the significance was 
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0.398. This is the indicator of probability that the null hypothesis is true. Significance in 
the SPSS output is the label for the p-value. 
When reviewing unstandardized coefficients in the regression analysis, the 
constant beta (B), the intercept of the model, was 7,575,313.704 and the Quality Score B 
was -5,085,463.502. Unstandardized beta (B) represents the line slope between the 
predictor and dependent variables. The constant standard error was 5,600,559.631 and the 
Quality Score standard error was 6,011,722.724. When reviewing unstandardized 
coefficients, there was no constant beta. The Quality Score beta was -0.036. The constant 
t was 1.353 and the Quality Score t was -0.846. The constant significance was 0.177. The 
Quality Score significance was 0.398. At a 95.0% confidence interval for B, the constant 
lower bound was -3,425,967.996, the constant upper bound was 18,576,595.405, the 
Quality Score lower bound was -16,894,400.386 and the Quality Score upper bound was 
6,723,473.382. There is not a statistical significance. These statistics show the strength of 
the effect of the independent to the dependent variable. In summary, Quality Score does 
not have a strong impact on other variables. 
Statistical assumptions were evaluated as appropriate to this study. The residual 
statistics, difference between observed and mean value, show a predicted value minimum 
of 2,489,850.25, a residual minimum of -48,233,604.000, a standard predicted value 
minimum of -1.030 and a standard residual minimum of -4.983 as well as a predicted 
value maximum of 5,263,970.50, a residual maximum of 109,567,624.000, a standard 
predicted value maximum of 6.894 and a standard residual maximum of 11.320. The 
predicted value mean was 2,850,592.38. The residual mean was 0.000. The standard 
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predicted value mean was 0.000. The standard residual mean was 0.000. The predicted 
value standard deviation was 350,092.853. The residual standard deviation was 
9,670,478.547. The standard predicted value standard deviation was 1.000. The standard 
residual standard deviation was 0.999. The N (population) was 548 for predicted value, 
residual, standard predicted value, and standard residual. The predictions and residuals 
note no statistical significance. These findings indicate the extent of the model’s account 
of observed data variation. Ultimately, the predictions varied from the observations.  
The data analysis indicates that Quality Score is not a statistically significant 
predictor of Generated Total Savings/Losses in the 2018 performance year; meaning, 
regardless of a 2018 participating MSSP ACO’s Quality Score, there is not a significant 
impact on their Generated Total Savings or Losses. The statistical analysis findings of the 
unstandardized B are not statistically significant. For every increase in Quality Score, 
Generated Total Savings/Losses decreased by $5.6 million. The confidence interval 
includes the value of 0; this is not a statistically significant result. The Quality Score 
significance is 0.398. In statistical analysis, if the p-value is less than 0.05, it is 
statistically significant. As 0.398 is greater than 0.05, the p-value is not statistically 
significant. The data relays that there is no statistically significant argument that there is a 
relationship between Quality Score and Generated Total Savings/Losses; there is no 
correlation between the two variables. 
Review of the data visualizations for RQ1 via Histogram, Normal P-P Plot of 
Regression Standardized Residual and Scatterplot were appropriate and characterized the 
sample. This study did not require post-hoc analyses or related reported results. There 
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was no need to report any additional statistical tests of hypotheses that emerged from the 
analysis of main hypotheses for the study. All pertinent tables and figures to illustrate 
results were included herein. 
Regression 
Table 5  
Variable Statistics 
 Mean Std. Deviation N 
Generated Total Savings/Losses 2850592.38 9676813.542 548 
Quality Score .929064 .0688419 548 
 




Savings/Losses Quality Score 
Pearson Correlation Generated Total 
Savings/Losses 
1.000 -.036 
Quality Score -.036 1.000 
Sig. (1-tailed) Generated Total 
Savings/Losses 
. .199 
Quality Score .199 . 






Table 7  
Variables Entered/Removed 
Model Variables Entered Variables Removed Method 
1 Quality Scoreb . Enter 
a. Dependent Variable: Generated Total Savings/Losses 
b. All requested variables entered. 
Table 8  
Model Summary 
Model R R Square 
Adjusted 
R Square 






Change df1 df2 
1 .036a .001 -.001 9679330.245 .001 .716 1 546 
Model 
Change Statistics 
Sig. F Change 
1 .398 
a. Predictors: (Constant), Quality Score 






Table 9  
ANOVA 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 67043058040096.000 1 67043058040096.000 .716 .398b 
Residual 51154430963240432.000 546 93689433998608.840 
  
Total 51221474021280528.000 547    
a. Dependent Variable: Generated Total Savings/Losses  
b. Predictors: (Constant), Quality Score 
 









95.0% Confidence Interval for 
B 





1 (Constant) 7575313.704 5600559.631  1.353 .177 -3425967.996 18576595.405 
Quality 
Score 
-5085463.502 6011722.724 -.036 -.846 .398 -16894400.386 6723473.382 




Table 11  
Residuals Statistics  
 Minimum Maximum Mean 
Std. 
Deviation N 
Predicted Value 2489850.25 5263970.50 2850592.38 350092.853 548 
Residual -48233604.000 109567624.000 .000 9670478.547 548 
Std. Predicted 
Value 
-1.030 6.894 .000 1.000 548 
Std. Residual -4.983 11.320 .000 .999 548 
a. Dependent Variable: Generated Total Savings/Losses 
 
Figure 4  





The DV Generated Total Savings/Losses Histogram depicts the frequency and 
regression standardized residual of 2018 performance year MSSP ACOs: whether they 
saved or lost millions of U.S. dollars. The x-axis shows the losses or savings. The y-axis 
shows the number of 2018 performance year MSSP ACOs. This chart shows how often 
Generated Total Savings/Losses occurs. Visually, 0 was the most frequent occurrence. 
Meaning, most of the 2018 MSSP ACOs had $0 in Generated Total Savings/Losses. 
Figure 5  
Normal P-Plot – DV: Generated Total Savings/Losses 
 
 
The DV Generated Total Savings/Losses Normal P-Plot of Regression 
Standardized Residual depicts probability of 2018 performance year MSSP ACOs. The x-
axis shows the observed cumulative probability. The y-axis shows the expected 
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cumulative probability. This chart shows the observation of Generated Total 
Savings/Losses occurrence and the expectation of Generated Total Savings/Losses 
occurrence was not aligned.  
Figure 6  
Scatterplot – DV: Generated Total Savings/Losses 
 
 
The DV Generated Total Savings/Losses Scatterplot depicts predicted and 
residual standardized regression. The x-axis shows regression standardized predicted 
value. The y-axis shows the regression standardized residual of 2018 performance year 
MSSP ACOs. This chart shows that most participating MSSP ACOs in the 2018 
performance year had around $0 of Generated Total Savings/Losses. There were outliers, 
but not enough to totally skew the clear visualization that most 2018 MSSP ACOs are 
scattered around the $0 savings mark. 
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After reviewing RQ1, the researcher/analyst used SPSS to run a simple linear 
regression analysis (SPSS: Analyze à Regression à Linear) for RQ2 with the same 
accompanying Statistics options chosen in SPSS for the RQ1 analysis: Estimates, 
Confidence Intervals at 95%, Model Fit, R Squared change, and Descriptives. 
Additionally, the Plots option was chosen in SPSS to include histogram and normal 
probability plot.  
RQ2: Is there a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants? 
H02: There is no statistically significant relationship between the Quality Score 
and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program 
Accountable Care Organization participants. 
H12: There is a statistically significant relationship between the Quality Score and 
Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable 
Care Organization participants. 
After analyzing the dataset, the null hypothesis was accepted and showed to be 
the true hypothesis. The analysis yielded results showing no statistically significant 
relationship between Quality Score and Total Assigned Beneficiaries for 2018 Medicare 
Shared Savings Program Accountable Care Organization provider participants. The data 
depicted a very low likelihood that Quality Score in 2018 MSSP ACOs was impacted by 
Total Assigned Beneficiaries. Meaning, if Total Assigned Beneficiaries changed (up or 
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down), Quality Score did not vary tremendously. In summary, Total Assigned 
Beneficiaries was not a predictor of Quality Score 
The variables for RQ2 were Quality Score and Total Assigned Beneficiaries, both 
scale variables. As such, Quality Score was the dependent variable shown on the vertical 
Y-axis and Total Assigned Beneficiaries was the independent predictor (constant) 
variable displayed on the horizontal X-axis. Dependent and independent variables were 
updated for SPSS analysis, as described herein.  
The variable statistics ran show that the mean Quality Score was 0.93 and the 
mean of Total Assigned Beneficiaries was 18,425. The average participating MSSP ACO 
in the 2018 performance year had a Quality Score of .93 and managed 18,425 members.  
The Pearson correlation results for Quality Score and Total Assigned 
Beneficiaries were 1.000 and 0.007. This depicts an estimated 0.7% correlation between 
Quality Score and Total Assigned Beneficiaries. The data showed that there is a very low 
likelihood that Quality Score in 2018 MSSP ACOs was impacted by Total Assigned 
Beneficiaries.  
The significance (one-tailed) for Quality Score and Total Assigned Beneficiaries 
was 0.432. The difference between the observations is not statistically significant and the 
null hypothesis is accepted. The results for RQ2 (is there a statistically significant 
relationship between the Quality Score and Total Assigned Beneficiaries for 2018 
Medicare Shared Savings Program Accountable Care Organization participants?) were 
that there was not a statistically significant relationship between Quality Score and Total 
Assigned Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care 
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Organization participants. The null hypothesis (there is no statistically significant 
relationship between the Quality Score and Total Assigned Beneficiaries for 2018 
Medicare Shared Savings Program Accountable Care Organization participants) was 
accepted. The alternative hypothesis (there is a statistically significant relationship 
between the Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared 
Savings Program Accountable Care Organization participants) was rejected. 
The model summaries included R of 0.007, R square of 0.000, adjusted R square 
of -0.002, standard error of the estimate at 0.0689031, R square change of 0.000, F 
change at 0.029, df1 at 1 and df2 at 546 with change statistics of significant F change at 
0.865. The 0.000 R square at 0/0 (0%) explains the variation is nothing. Meaning, if Total 
Assigned Beneficiaries changes (up or down), Quality Score does not vary at all; thus, 
there is no statistical significance. In summary, the dataset shows Total Assigned 
Beneficiaries is not a predictor of Quality Score.  
ANOVA analysis showed the regression sum of squares as 0.000. Regression sum 
of square depicts how well a regression model represents the data being modeled. A low 
sum of squares means the regression model fits the data well. ANOVA analysis showed 
residual sum of squares as 2.592 with a total of 2.592. Residual sum of square measures 
modeling error variation. The regression mean square was 0.000; meaning, the model is 
perfect. The residual mean square was 0.005. The regression F was 0.029 and the 
regression significance was 0.865. This is the indicator of probability that the null 
hypothesis is true. Significance in the SPSS output is the label for the p-value. 
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When reviewing unstandardized coefficients in the regression analysis, the 
constant B was 0.929 and the Total Assigned Beneficiaries B was 2.698E-8, while the 
constant standard error was 0.004 and the Total Assigned Beneficiaries standard error 
was 0.000. When reviewing standardized coefficients, there was no constant beta. The 
Total Assigned Beneficiaries beta was 0.007. The constant t was 223.862 and the Total 
Assigned Beneficiaries t was 0.170. The constant significance was 0.000. The Total 
Assigned Beneficiaries significance was 0.865. At a 95% confidence interval for B, the 
constant lower bound was 0.920. The constant upper bound was 0.937. The Total 
Assigned Beneficiaries lower bound was 0.000 and the Total Assigned Beneficiaries 
upper bound was 0.000. Meaning, there is not a statistical significance. These statistics 
show the strength of the effect of the independent to the dependent variable. In summary, 
Total Assigned Beneficiaries does not have a strong impact on other variables. 
Statistical assumptions were evaluated as appropriate to this study. The residual 
statistics showed a predicted value minimum of 0.928583, a residual minimum of -
0.4750648, a standard predicted value minimum of -0.959 and a standard residual 
minimum of -6.895 as well as a predicted value maximum of 0.932278, a residual 
maximum of 0.0713072, a standard predicted value maximum of 6.412 and a standard 
residual maximum of 1.035. The predicted value mean was 0.929064. The residual mean 
was 0.0000000. The standard predicted value mean was 0.000. The standard residual 
mean was 0.000. The predicted value standard deviation was 0.0005012. The residual 
standard deviation was 0.0688401. The standard predicted value standard deviation was 
1.000. The standard residual standard deviation was 0.999. The population was 548 for 
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predicted value, residual, standard predicted value, and standard residual. The predictions 
and residuals note no statistical significance. 
The dataset shows that Total Assigned Beneficiaries is not a predictor of Quality 
Score. The statistical analysis findings of the unstandardized B are not statistically 
significant because for every increase in Total Assigned Beneficiaries, Quality Score 
decreased by 0.004 (0.4%). The confidence interval includes the value of 0; this is not a 
statistically significant result. The Total Assigned Beneficiaries significance is 0.865. In 
statistical analysis, if the p-value is less than 0.05, it is statistically significant. As 0.865 is 
greater than the p-value, it is not statistically significant. The data relays that there is no 
statistically significant argument that there is a relationship between Total Assigned 
Beneficiaries and Quality Score; there is no association between the two variables. 
Review of the data visualizations for RQ 2 via histogram, normal p-plot of 
regression standardized residual and scatterplot were appropriate and characterized the 
sample. There was not a need in this study for post-hoc analyses of statistical tests. Thus, 
there were no reported results of such. Additionally, there was no need to report any 
further statistical tests of hypotheses that emerged from the main hypotheses. All 





Table 12  
Variable Statistics 
 Mean Std. Deviation N 
Quality Score .929064 .0688419 548 
Total Assigned Beneficiaries 18424.95 18572.682 548 
 
Table 13  
Correlations 
 Quality Score 
Total Assigned 
Beneficiaries 
Pearson Correlation Quality Score 1.000 .007 
Total Assigned Beneficiaries .007 1.000 
Sig. (1-tailed) Quality Score . .432 
Total Assigned Beneficiaries .432 . 
N Quality Score 548 548 
Total Assigned Beneficiaries 548 548 
 
Table 14  
Variables Entered/Removed 
Model Variables Entered Variables Removed Method 
1 Total Assigned 
Beneficiariesb 
. Enter 
a. Dependent Variable: Quality Score 


















Change df1 df2 
1 .007a .000 -.002 .0689031 .000 .029 1 546 
Model 
Change Statistics 
Sig. F Change 
1 .865 
a. Predictors: (Constant), Total Assigned Beneficiaries  
b. Dependent Variable: Quality Score 
Table 16  
ANOVA  
Model Sum of Squares df Mean Square F Sig. 
1 Regression .000 1 .000 .029 .865b 
Residual 2.592 546 .005   
Total 2.592 547    
a. Dependent Variable: Quality Score 
















B Std. Error Beta 
Lower 
Bound 
1 (Constant) .929 .004  223.862 .000 .920 
Total Assigned 
Beneficiaries 
2.698E-8 .000 .007 .170 .865 .000 
Model 
95.0% Confidence Interval 
for B 
Upper Bound 
1 (Constant) .937 
Total Assigned Beneficiaries .000 
 
Table 18  
Residuals Statistics 
 Minimum Maximum Mean Std. Deviation N 
Predicted Value .928583 .932278 .929064 .0005012 548 
Residual -.4750648 .0713072 .0000000 .0688401 548 
Std. Predicted Value -.959 6.412 .000 1.000 548 
Std. Residual -6.895 1.035 .000 .999 548 




Figure 7  
Histogram – DV: Quality Score 
 
 
The DV Quality Score histogram depicts the frequency of regression standardized 
residual. The x-axis shows the regression standardized residual. The y-axis shows 
frequency of 2018 performance year MSSP ACOs. This chart shows how often (how 
many participating MSSP ACOs in the 2018 performance year) had a certain Quality 
Score. Visually, a score of 1 (between 0 and 2) was the most frequent occurrence. 
Meaning, most of the 2018 MSSP ACOs had a Quality Score of 1. 
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Figure 8  
Normal P-Plot – DV: Quality Score 
 
 
The DV Quality Score normal p-plot of regression standardized residual depicts 
probability of 2018 performance year MSSP ACOs. The x-axis shows the observed 
cumulative probability. The y-axis shows the expected cumulative probability. This chart 
shows the expectations of probability of Quality Score occurrence and the expected 
probability of Quality Score occurrence was close from 0 through 0.8 then the observed 
probability tapered off.  
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Figure 9  
Scatterplot – DV: Quality Score 
 
 
 The DV Quality Score scatterplot depicts predicted and residual standardized 
regression. The x-axis shows regression standardized predicted value. The y-axis shows 
the regression standardized residual of 2018 performance year MSSP ACOs. This chart 
shows that most participating MSSP ACOs in the 2018 performance year had a Quality 
Score of 1. There were outliers, but not enough to totally skew the clear visualization that 
most Quality Scores are scattered around 1.  
Summary 
After the secondary dataset was quantitatively analyzed, I was able to review the 
study’s two research questions, understand the statistically significant relationships 
between Quality Score and Generated Total Savings/Losses as well as Quality Score as 
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Total Assigned Beneficiaries for MSSP ACO participants in the 2018 performance year 
and note if each of the null and alternative hypotheses were respectively accepted or 
rejected.  
The results for RQ1 (is there a statistically significant relationship between the 
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings 
Program Accountable Care Organization participants?) were that there was not a 
statistically significant relationship between Quality Score and Generated Total 
Savings/Losses for 2018 Medicare Shared Savings Program Accountable Care 
Organization participants. The null hypothesis (there is no statistically significant 
relationship between the Quality Score and Generated Total Savings/Losses for 2018 
Medicare Shared Savings Program Accountable Care Organization participants) was 
accepted. The alternative hypothesis (there is a statistically significant relationship 
between the Quality Score and Generated Total Savings/Losses for 2018 Medicare 
Shared Savings Program Accountable Care Organization participants) was rejected.  
The findings for RQ1 were that there was no statistically significant relationship 
between Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared 
Savings Program Accountable Care Organization provider participants. The data showed 
a very low likelihood that their Quality Score impacted Generated Total Savings (or) 
Losses in 2018 MSSP ACOs. Meaning, if Quality Score changed (up or down), 
Generated Total Savings/Losses did not vary tremendously; thus, the statistical 
significance was low. The data showed no statistically significant argument that there is a 
relationship between Quality Score and Generated Total Savings/Losses; there is no 
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correlation between the two variables. In summary, the dataset shows that Quality Score 
was not a predictor of Generated Total Savings/Losses. 
Any potential notion that 2018 MSSP ACO participants’ Generated Total 
Savings/Losses in 2018 MSSP ACOs could be impacted by Quality Score is refuted by 
these findings. This study’s findings are important to MSSP ACO policy creation and 
program management. MSSP ACOs stakeholders (proponents and opponents alike) 
would likely want to review findings that show a lack of statistical significance between 
Quality Score and Generated Total Savings/Losses for 2018 MSSP ACOs. This is critical 
to note because of the idea that one cannot assume that a certain Quality Score predicts 
the potential for savings or losses.  
The results for RQ2 (is there a statistically significant relationship between the 
Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings 
Program Accountable Care Organization participants?) were that there was not a 
statistically significant relationship between Quality Score and Total Assigned 
Beneficiaries for 2018 Medicare Shared Savings Program Accountable Care 
Organization participants. The null hypothesis (there is no statistically significant 
relationship between the Quality Score and Total Assigned Beneficiaries for 2018 
Medicare Shared Savings Program Accountable Care Organization participants) was 
accepted. The alternative hypothesis (there is a statistically significant relationship 
between the Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared 
Savings Program Accountable Care Organization participants) was rejected.  
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The findings for RQ2 were that there was no statistically significant relationship 
between Quality Score and Total Assigned Beneficiaries for 2018 Medicare Shared 
Savings Program Accountable Care Organization provider participants. The data showed 
that there is a very low likelihood that Total Assigned Beneficiaries impacted Quality 
Score in 2018 MSSP ACOs. Meaning, if Total Assigned Beneficiaries changed (up or 
down), Quality Score did not vary tremendously; thus, the statistical significance was 
low. The data showed no statistically significant argument that there is a statistically 
significant relationship between Quality Score and Total Assigned Beneficiaries; there is 
no correlation between the two variables. In summary, the dataset shows that Total 
Assigned Beneficiaries was not a predictor of Quality Score. 
Any potential notion that 2018 MSSP ACO participants’ Quality Score in 2018 
MSSP ACOs could be impacted by Total Assigned Beneficiaries is refuted by these 
findings. The findings are important to MSSP ACO policy creation and program 
management. MSSP ACOs stakeholders (proponents and opponents alike) would likely 
want to review findings that show a lack of statistical significance between Quality Score 
and Total Assigned Beneficiaries for 2018 MSSP ACOs. This is critical to note because 
one cannot assume that the total number of assigned beneficiaries predicts a certain 
Quality Score.  
Important to recall are some notes from the literature review: the overarching goal 
of the MSSP should not be how many ACOs participate, but how successful those that do 
participate are in improving patient care (Meltzer, 2018) and sound management of 
quality could yield better beneficiary health care patterns (Beaton, 2018).  
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Section 4 will review the purpose of the doctoral research study, the reason the 
study was conducted, the key findings and interpretations of such, limitations of the 
study, recommendations for future research, and applications to professional practice and 
implications for social change.  
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Section 4: Application to Professional Practice and Implications for Social Change 
The purpose of this study was to review and understand the relationship between 
generated total savings/losses, Quality Score, and total assigned beneficiaries for 2018 
MSSP ACO participants. For this quantitative study, I used secondary data to address two 
research questions. This study needed to be conducted on a micro level to note the 2018 
performance year relationship of quality and cost indicators for the managed population 
of the MSSP. On a macro level, this study needed to be conducted to understand the 
impact MSSPs have on the overarching U.S. health care goals to increase quality and 
decrease costs for managed populations in the Medicare space, moving more towards 
value-based care.  
Even though the data analysis results showed no statistically significant 
relationship between Quality Score and Generated Total Savings/Losses nor between 
Quality Score and Total Assigned Beneficiaries for 2018 MSSP ACO provider 
participants, this study contributed to positive social change by creating a new vantage 
point for review of their quality, costs, and assigned beneficiaries. The development and 
understanding of ACO initiatives are essential pieces required for meeting federal value-
based care and alternative payment model U.S. health care goals. From a quality 
perspective, this is critical for Medicare beneficiaries and from a cost perspective, this is 
important for U.S. taxpayers. Other methods one could use to better understand the 
relationship between quality and cost may be to review cost of services rendered by 
different provider types (e.g., specialist, primary care provider, or other advanced 
practicing provider) or diagnosis across various service points (e.g., inpatient or 
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outpatient FQHCs, RHCs, SNFs, surgical centers, rehabilitation centers, etc.). 
Additionally, reviewing geography, ethnicity, gender, and/or age groups would likely 
yield different results than those found in this study.  
The data statistics consisted of public data from the CMS, a federal resource, for 
the MSSP ACO 2018 performance year. This allowed me to employ recent data via a 
standard analytical file to efficiently summarize information for Medicare beneficiaries 
and ACO providers for the 2018 performance year of the MSSP. In this research study, I 
noted the relationship amongst Generated Total Savings/Losses, Quality Score, and Total 
Assigned Beneficiaries, reviewed the literature, and presented potential further research 
on whether MSSP ACOs can be considered as a way to lower costs and increase quality 
as it relates to serving the Medicare population. The results of this study showed no 
statistical significance between Quality Score and Generated Total Savings/Losses and no 
statistical significance between Quality Score and Total Assigned Beneficiaries. 
Understanding these results, further research could focus on other MSSP ACO 
performance years, addition of further variables (within the constraints of MSSP ACOs 
or not) or other variables impacting overall quality and cost.  
In RQ1, the predictor/independent variable was Quality Score and the 
outcome/dependent variable was Generated Total Savings/Losses. The key findings from 
the data analysis were that there was no statistically significant relationship between 
Quality Score and Generated Total Savings/Losses for 2018 Medicare Shared Savings 
Program Accountable Care Organization provider participants. The null hypothesis was 
accepted and the alternative hypothesis was rejected. The results of the simple linear 
94 
 
regression data analysis indicated there was a very low likelihood (i.e., no statistically 
significant relationship) that the Quality Score impacted Generated Total Savings (or) 
Losses in 2018 MSSP ACOs, meaning that if Quality Score changed (up or down), 
Generated Total Savings/Losses did not vary tremendously. In summary, the dataset 
review showed that Quality Score was not a predictor of Generated Total Savings/Losses. 
In RQ2, the predictor/independent variable was Total Assigned Beneficiaries and 
the outcome/dependent variable was Quality Score. The simple linear regression data 
analysis concluded that there was no statistically significant relationship between Quality 
Score and Total Assigned Beneficiaries for 2018 Medicare Shared Savings Program 
Accountable Care Organization provider participants. The null hypothesis was accepted 
and the alternative hypothesis was rejected. The data indicated there was a very low 
likelihood (i.e., no statistically significant relationship) that Total Assigned Beneficiaries 
impacted Quality Score in 2018 MSSP ACOs. In other words, if Total Assigned 
Beneficiaries changed (up or down), Quality Score did not vary tremendously. In 
summary, the dataset review noted that Total Assigned Beneficiaries was not a predictor 
of Quality Score. 
The findings of the research questions are important. While, quantitatively, this 
study’s results found that there were no statistically significant findings for either 
research question, future analysts of the same dataset could review other variables outside 
of those analyzed herein: Quality Score, Generated Total Savings/Losses and Total 
Assigned Beneficiaries of 2018 MSSP ACOs to find some levels of statistically 
significance related to quality and costs of the assigned beneficiaries. Examples of 
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variables that could be studied include, but are not limited to, ACO participation start 
date, track, type, SNF waiver participant, benchmark, revenue expense category and per 
capita expenses. Additionally, the statistical significance of the relationship amongst 
Quality Score, Generated Total Savings/Losses and Quality Score and Total Assigned 
Beneficiaries could be studied for other MSSP ACO performance years (e.g., 2012, 2013, 
2014, 2015, 2016, 2017, 2019 and beyond). Additionally, reviewing patient satisfaction 
surveys specifically related to quality of care could create an avenue of additional 
research.  
Interpretation of the Findings 
The data analysis findings contrasted with the literature review presented in 
Section 1 of this study. Whereas the literature pointed to variable (cost, quality, attributed 
beneficiaries) connectivity, the data analysis did not yield a statistical significance 
between the independent and dependent variables included in the research questions.  
In terms of the theoretical framework, the study’s findings align with GST, as 
noted earlier in this work. U.S. health care is a system with complex interacting elements, 
continually evolving parts, emerging properties, and broad concepts in a dynamic and 
active ecosphere with various outcomes. GST is applicable and helps make sense of the 
contrasting literature review and data analysis. Since the data analysis showed no 
statistical significance between Quality Score, Generated Total Savings/Losses, and Total 
Assigned Beneficiaries, there could be randomness occurring with MSSP ACOs 
increasing quality and decreasing cost overall. The fact that various layers exist in the 
system that relates their intersecting trends and patterns helps a reviewer understand 
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behaviors of interrelatedness and interdependence can differ quantitatively versus 
qualitatively.  
The scope of the study allowed for analysis and interpretation of the data. The 
findings showed no statistically significant relationship between Quality Score and 
Generated Total Savings/Losses, and there was no statistically significant relationship 
between total Assigned Beneficiaries for 2018 MSSP ACOs.  
Limitations of the Study 
This work's limitations included data, analysis, and trending reports provided by 
the federal government and engaged, interested, likely proponents, and/or participating 
organizations of MSSPs for the years of implementation, participation, and reporting. 
Therefore, the findings in terms of quality, cost and beneficiaries (Quality Score does not 
have a statistically significant relationship with Total Generated Savings/Losses and 
Quality Score does not have a statistically significant relationship with Total Assigned 
Beneficiaries) cannot be representative of the entire health care system nor even all of the 
Medicare-eligible population (as a large percentage of beneficiaries participate in a 
Medicare Advantage plan or none, at all) and does not compare MSSP ACOs to non 
MSSPs ACO that may also be generating a higher value for the same variables of this 
study. While the Medicare FFS program may show that certain MSSP ACOs have 
generated savings for that specific sector of the population, it does not negate that the 
entire system’s cost could still be rising, and quality could still be declining.  
The challenges that arise when one attempts to review a relatively new program in 
a dynamic environment in an evolving, ever-changing system are that things do not 
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remain static. It is difficult to ensure sound statistical analysis when there are frequent 
changes, year-over-year, to the quality measures or the cost-savings factors. Systematic 
and technical adjustments, as well as realignment, must be made by providers that may 
cause indifferent results. It is difficult to measure certain quality metrics when there are 
so many outlying issues affecting the result. One must review data and reasoning but 
understand there are retrospective changes that occur and arguments to the methodology 
that make sense in the space that must be considered. Other initiatives, alternative and 
bundled payment methodologies, changes in Medicare rules, inpatient and outpatient 
treatment differentials, skilled nursing and rehabilitation components, and various other 
advents of evidence-based practices geared toward ensuring proper care across all 
provider types can have a compounding, comprehensive effect on MSSP ACOs quality, 
costs, and attributed beneficiaries. These extraneous variables change constantly 
throughout a MSSP ACO’s performance year and have an impact on cost and quality.  
The data analysis allowed for further audit of generalizability limitations. One 
cannot consider the general notion that all Medicare beneficiary pools would yield this 
study’s same results in terms of cost and quality relationships. Relatedly, there cannot be 
a generalization made that all MSSP ACO provider participants in various performance 
years would render services that result in similar findings. It can be generalized that 
Medicare beneficiaries are not all treated equitably in terms of accountable care service 
renderings and outcomes-based measurement amongst different providers across various 
programs in disparate geographies.  
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The trustworthiness of the findings was as deep and broad as the CMS data 
sharing would allow. The CMS’ MSSP ACO program follows data integrity and 
transparency principles appropriate for federal source data. As noted earlier in this work, 
the data's validity via the published dataset on the CMS government website has been 
argued as unable to predict counterfactual scenarios. Specifically, it is hard to know what 
would have been spent on CMS covered benefits for the population served if ACOs did 
not exist (LaPointe, 2017). This instrument was previously used in performance years 
2012, 2013, 2014, 2016, and 2017 with the same Medicare population but with slightly 
different measures and modes of interpretation. 
The data's validity does not consider other potential interaction effects and 
reactiveness of arrangements or program participation maturity, experimental mortality, 
equitable risk ownership, and selection interaction. 
Also noted earlier in this study, the reliability concerns that arose with the 
secondary data set included the difficulty, or near impossibility, of extracting the effects 
that other Medicare changes, regulations and programs have on the MSSP. For example, 
and as previously noted in this study, changes in Medicare rules regarding inpatient days, 
bundled payments for services, and other advents geared toward ensuring proper care 
across all provider types can and will very likely have a compounding, comprehensive 
effect on other initiatives being studied, such as MSSP ACOs. This is beyond the scope 




This study reviewed Quality Score, Generated Total Savings/Losses, and Total 
Assigned Beneficiaries of MSSP ACOs in the 2018 performance year. Recommendations 
for further research include expanding the review to analyze other MSSP ACO variables 
such as expenses per capita, place of service, admission rates, number of managed 
beneficiaries, Hierarchical Condition Category (HCC) risk scores of certain conditions; 
related to geography, age range, race and/or gender or assessing other performance years’ 
MSSP ACO dataset. By expanding the review, analyzing additional variables and/or 
assessing different performance years, it could benefit interested parties to provide 
expanded context on overall MSSP ACO success 
Another option for future research could be to analyze the same independent and 
independent variables of this study, but for other MSSP ACO performance years to 
confirm, refute and/or compare this study’s findings. In addition to the opportunity to 
review performance years 2012-2017, reviewing 2019 MSSP ACO data (and 2020 when 
it becomes publicly available in late 2021) would be appropriate to understand year-over-
year matured variation in the three variables reviewed in this study. These 
recommendations are grounded in the strengths and limitations of the current study and 
literature reviewed in Section 1 and did not exceed the study boundaries.  
As Falk (2016) noted, there have been studies that showed statistically significant 
correlations of data elements related to MSSP ACO generated savings, but none to date, 
that analyze the relationship between costs and quality as it relates to total assigned 
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beneficiaries. This study helps fill the gap that Falk (2016) examined (on 2014 MSSP 
data) that was present at the time of writing.  
Implications for Professional Practice and Social Change 
Professional Practice  
A competitive strategic approach for health care administrators leading various 
health care organizations is in many ways dependent on properly understanding the 
relationship of quality and cost measures to the population under organizational 
management (Arsita & Idris, 2019). For example, quality improvements could lead to an 
increase in generated total savings.  
This study offers health care administrative and clinical professionals’ practical 
evidence and understanding of the relationship between Quality Score, Generated Total 
Savings/Losses, and Total Assigned Beneficiaries among 2018 MSSP ACOs and what 
could continue to be examined in the future as it relates to the MSSP. The extraneous 
variables noted in this study could be addressed and opportunities and/or suggestions for 
control could be provided. The literature review helped support the professional practice 
of health care, in general. It demonstrated practical application by presenting that MSSP 
ACOs may be an avenue for reaching the overarching U.S. health care system goals of 
achieving better care for individuals and better health for populations while lowering the 
growth in expenditures (National Association of ACOs, 2018).  
The results of this study yield no statistically significant relationship between 
Quality Score and Generated Total Savings/Losses nor between Quality Score and Total 
Assigned Beneficiaries for 2018 MSSP ACO provider participants. The outcomes of this 
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research allow for further understanding of the statistical significance between cost, 
quality, and beneficiaries. This examination of 2018 MSSP ACOs renders useful findings 
that can either confirm or refute MSSP ACO stakeholder thoughts and opinions and 
initiate potential next steps relevant to organizational needs. By utilizing this evidence, 
interested parties can better understand the statistically significant relationship between 
cost, quality, and beneficiary variables in the 2018 MSSP ACO performance year data. 
Stakeholders can use this information to argue for or against further advancing MSSP 
ACOs. For example, as this study’s findings yield there is no statistically significant 
relationship between Quality Score and Total Generated Savings/Losses, one could argue 
for 2018 MSSP ACO participants that it does not matter what the Quality Score is, there 
is not a predictability factor for Total Generated Savings/Losses as it relates to the MSSP. 
Similarly, as this study’s findings yield there is no statistically significant relationship 
between Quality Score and Total Assigned Beneficiaries, one could argue that it doesn’t 
matter how large the attributed managed population is, there is not a predictability related 
to overall Quality Score.  
As previously noted in this study, extraneous variables likely played a role in the 
results of this analysis. For example, this study did not take into account if the reviewed 
2018 MSSP ACO participants engaged in any other CMS healthcare transformation 
efforts under accountable care (such as the Comprehensive End-Stage Renal Disease 
Care Model, the Medicare Health Care Quality Demonstration and the Vermont All-
Payer ACO Model), episode-based payment initiatives (such as Bundled Payments for 
Care Improvement Initiative, Comprehensive Care for Joint Replacement Model and 
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Oncology Care Model) nor primary care transformation (Comprehensive Primary Care 
Plus, Independence at Home Demonstration and Primary Care First Model).  
As such, there are serious practical implications and recommendations for 
professional practice. For example, NAACOs and other MSSP ACO proponents are 
interested in understanding the statistical significance of related elements (cost and 
quality included) that lead to the maturation of U.S. value-based health care. PPACA was 
predicated and the Center for Medicare and Medicaid Innovation has built further policies 
into the assumption and assertion that population health can be managed to increase the 
overall quality and decrease cost.  
The methodological implications were grounded in a non-experimental research 
design using secondary data quantitative analysis of a PUF. This method was used 
because the data variables were studied but not manipulated in any way. The researcher 
had specific research questions and hypothesized the relationships among the 
independent and dependent variables. The methodology of inquiry was a systematic 
review and strategic analysis of said publicly available secondary data for MSSP ACO 
participants in the 2018 performance year to note the relationship between Quality Score 
to Generated Total Savings/Losses and Quality Score to Total Assigned Beneficiaries.  
Theoretically, basing this study on GST allowed the researcher to review a 
complex system with interrelated and evolving parts. This study examined the 2018 
MSSP ACO performance year, noting how participants behaved in the ever-changing 
health care environment and specifically reviewed the relationship between three 
different variables (Quality Score, Generated Total Savings/Losses, and Total Assigned 
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Beneficiaries). The implications of this study’s theoretical foundation allowed for 
correlating how value-based care may help improve the U.S. health care system and 
understand the statistically significant relationship among the analyzed variables. 
Implications from an empirical perspective included the data analysis that yielded 
no statistically significant relationship between Quality Score and Generated Total 
Savings/Losses, and there was no statistically significant relationship between Quality 
Score and Total Assigned Beneficiaries for 2018 MSSP ACO provider participants. This 
study’s findings imply that Quality Score was not a predictor of Generated Total 
Savings/Losses and Total Assigned Beneficiaries was not a predictor of Quality Score for 
2018 MSSP ACO performance year data. 
Positive Social Change 
Interested parties look to better understand how MSSP ACOs will lead to positive 
social change for health care stakeholders of all kinds: patients, providers, public payers, 
private constituents, policymakers, researchers, and the like. If MSSP ACOs can decrease 
U.S. health care costs while concurrently increasing quality for managed populations, 
there is a compelling argument for their staying power in the system. If able to maintain 
momentum and prove transformative, MSSP ACOs could forever change the health care 
landscape. One of the essential components of understanding how to scale the success of 
MSSP ACOs is to relate the variables and understand their impact (or not) on each other.  
Success of value-based care and its ability to move the U.S. health care system 
toward higher quality and lower costs, will depend on understanding the markers of ACO 
success thus far, a continuation of initiatives that have worked well, and a development of 
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increased innovation geared towards improved quality and reduced costs (Moloney, 
2015). Also, of importance is the need to further strengthen the program for longevity and 
viability (Sweeney, 2018). 
This study reviewed the literature on MSSP ACOs and analyzed a public use file 
data set as it related to Generated Total Savings/Losses, Quality Score, and Total 
Assigned Beneficiaries in the 2018 performance year to understand the relationship 
between the variables. This study's findings have impacts for positive social change as it 
relates to value-based health care in the United States. Specifically, this study resulted in 
no statistically significant relationships between Quality Score and Generated Total 
Savings/Losses nor between Quality Score and Total Assigned Beneficiaries for 2018 
MSSP ACO participants. The findings provide interested parties insights into how these 
specific variables of 2018 MSSP ACOs were correlated and the impact they had on each 
other in the performance year. Quality Score was not a statistically significant predictor 
of Generated Total Savings/Losses, and Total Assigned Beneficiaries was not a 
statistically significant predictor of Quality Score. Stakeholders can use this information 
to create further avenues of awareness that certain variables may or may not have 
correlations. The implications noted for social change did not exceed the study 
boundaries.  
This study was conducted on a micro level to note the 2018 performance year 
relationship of quality and cost indicators for the managed population of the MSSP. On a 
macro level, this study was conducted to understand the relational impact MSSPs have on 
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the overarching U.S. health care goals to increase quality and decrease costs for managed 
populations in the Medicare space, moving more towards value-based care.  
This study's positive social change includes the understanding of the relationship 
between quality, cost and total assigned beneficiaries and the related movement toward 
value-based care in terms of lowered costs and increased quality for the U.S. health care 
system, specifically stemming from 2018 MSSP ACOs. From a quality perspective, this 
is critical for Medicare beneficiaries, and from a cost perspective, this is important for 
U.S. taxpayers.  
Conclusion 
In conclusion, this study reviewed the literature on MSSP ACOs and analyzed a 
public use file data set as it related to Generated Total Savings/Losses, Quality Score and 
Total Assigned Beneficiaries in the 2018 performance year to understand the relationship 
between the variables. The purpose of the doctoral research study, the reason the study 
was conducted, the key findings and interpretations of such, limitations of the study, 
recommendations for future research, and applications to professional practice and 
implications for social change, were reviewed herein.  
The literature review demonstrated that MSSP ACOs are an avenue to lower costs 
and increase quality related to serving Medicare beneficiaries. There were a multitude of 
sources that noted MSSP ACOs were a viable option for U.S. health care administrators 
to reach systemic goals due to their positive effect on cost and quality. Tu et al. (2015) 
posited that MSSP ACOs can help lessen the fragmentation and misalignment and move 
the United States towards more value-based health care renderings while improving 
106 
 
assigned population health and reducing costs. The National Association of Accountable 
Care Organizations (2018) argued that MSSP ACOs can help ensure care quality is 
enhanced. The OIG reported that most ACOs had instituted various strategies that have 
proven successful in lowering Medicare spending (King, 2019).  
 This study’s data analysis yielded findings that there was no statistically 
significant relationship between Quality Score and Generated Total Savings/Losses and 
there was no statistically significant relationship between Quality Score and Total 
Assigned Beneficiaries for 2018 MSSP ACO provider participants. Quality Score was not 
a predictor of Generated Total Savings/Losses, and Total Assigned Beneficiaries was not 
a predictor of Quality Score. 
It is an interesting circumstance and potentially controversial that the literature 
overarchingly argues MSSP ACOs increase quality and decrease costs for a particular 
managed patient population and the maturation of and participation in the program over 
time allows for further successes, but when the relationship of the pertinent variables is 
analyzed, there is no statistical significance between Quality Score and Generated Total 
Savings/Losses nor Quality Score and Total Assigned Beneficiaries.  
Even though the data analysis results showed no statistically significant 
relationship between Quality Score and Generated Total Savings/Losses and no 
statistically significant relationship between Quality Score and Total Assigned 
Beneficiaries for 2018 MSSP ACO provider participants, this study contributed to 
positive social change by creating a new vantage point for quantitative review of their 
quality, costs and assigned beneficiaries.  
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As noted earlier in this study, and still of importance to recall, is the value that 
MSSP ACOs bring to the overall U.S. health care system. The literature supports that 
MSSP ACOs with elevated quality scores yield higher shared savings.  
For future studies, qualitative, I would suggest looking at the same variables in a 
different manner or reviewing other/additional variables in the MSSP ACO dataset. 
Examples of various ways to look at the data in a quantitative manner include, but are not 
limited to, eliminating dollars spent on high-cost services, reviewing certain geographies 
and/or capturing only mature ACOs. Additionally, one could include patient satisfaction 
survey results, medical home loyalty, in-network service versus out-of-network service 
utilization and other factors to review Medicare beneficiary engagement in their overall 
health care. Engagement and satisfaction may better represent quality of care analysis in a 
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